0001065949-20-000144.txt : 20201104 0001065949-20-000144.hdr.sgml : 20201104 20201104104625 ACCESSION NUMBER: 0001065949-20-000144 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 46 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201104 DATE AS OF CHANGE: 20201104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO LAB NATURALS, INC. CENTRAL INDEX KEY: 0001803977 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS AMUSEMENT & RECREATION [7990] IRS NUMBER: 842288662 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-239640 FILM NUMBER: 201285594 BUSINESS ADDRESS: STREET 1: 201 COLUMBINE ST., 3RD FLOOR STREET 2: SUITE 11 CITY: DENVER STATE: CO ZIP: 80206 BUSINESS PHONE: 720-273-0433 MAIL ADDRESS: STREET 1: 201 COLUMBINE ST., 3RD FLOOR STREET 2: SUITE 11 CITY: DENVER STATE: CO ZIP: 80206 10-Q 1 blabform10qsept2020.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

(Mark One)

 

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020

 

[  ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from __________ to ___________

 

Commission file number: 333-239640

 

BIO LAB NATURALS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   84-2288662
(State of Incorporation)   (IRS Employer ID Number)

 

7400 E. Crestline Circle, Suite 130, Greenwood Village, CO 80111

(Address of principal executive offices)

 

(720) 273-0433

(Registrant’s Telephone number)

 

__________________________________

 

(Former Address and phone of principal executive offices)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
N/A N/A N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days.

Yes [X]   No [  ]

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 for Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes [X]   No [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [ ] Accelerated filer [ ]
Non-accelerated filer [X] Smaller reporting company [X]
  Emerging growth company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. [ ] 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [  ]   No [X]

 

Indicate the number of share outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

As of October 30, 2020, there were 10,753,504 shares of the registrant’s common stock, $0.0001 par value, issued and outstanding, not including shares reserved for conversion of notes. 

 

TABLE OF CONTENTS

 

    Page
  PART 1 – FINANCIAL INFORMATION  
     
Item 1. Financial Statements (Unaudited) 2
     
  Consolidated Balance Sheets – September 30, 2020 and December 31, 2019 2
     
  Consolidated Statements of Operations – Three and nine months ended September 30, 2020 and 2019 3
     
  Consolidated Statement of Changes in Stockholders’ Equity – Nine months ended September 30, 2020 5
     
  Consolidated Statements of Cash Flows – Nine months ended September 30, 2020 and 2019 6
     
  Notes to the Financial Statements 7
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 14
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk – Not Applicable 16
     
Item 4. Controls and Procedures 17
     
  PART II- OTHER INFORMATION  
     
Item 1. Legal Proceedings – Not Applicable 17
     
Item 1A. Risk Factors 17
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds - Not Applicable 18
     
Item 3. Defaults Upon Senior Securities – Not Applicable 18
     
Item 4. Mine Safety Disclosure – Not Applicable 18
     
Item 5. Other Information – Not Applicable 18
     
Item 6. Exhibits 18
     
  Signatures 19

 

1 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
     
     
         
         
    September 30,   December 31,
Assets   2020   2019
Current assets   (Unaudited)   (Audited)
 Cash   $ 122,752     $ 69,527  
 Accounts receivable, net     —         13,000  
 Prepaids     12,500       —    
    Total current assets     135,252       82,527  
    Equipment                
 Equipment, net of accumulated depreciation, $25,681     177,281       160,536  
                 
 Total Assets   $ 312,533     $ 243,063  
                 
 Liabilities and Stockholders' Equity                
    Current liabilities                
 Accounts payable   $ 16,456     $ 18,900  
 Due to related party     —         3,270  
 Total current liabilities     16,456       22,170  
    Total liabilities     16,456       22,170  
                 
 Commitments and Contingencies     —            
                 
 Stockholders' Equity                
 Preferred shares, $0.0001 par value, 5,000,000 shares authorized;                
    Class A Convertible, deemed par value $0.04 per share; 500,000                
      shares issued and outstanding at September 30, 2020 and                
      December 31, 2019     50       50  
 Common shares, $0.0001 par value, 200,000,000 shares authorized;                
    10,753,504 and 8,477,505 shares issued and outstanding at                
      September 30, 2020 and December 31, 2019, respectively     1,075       848  
 Additional paid in capital     35,672,338       35,388,065  
 Retained (deficit)     (35,377,386 )     (35,168,070 )
    Total stockholders' equity     296,077       220,893  
                 
 Total Liabilities and Stockholders' Equity   $ 312,533     $ 243,063  
                 
 The accompanying notes are an integral part of these financial statements.

 

2 

 

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
     
         
         
      Three Months Ended September 30,  
      2020       2019  
 Sales   $ 21,000     $ —    
                 
 Cost of sales                
 Cost of sales - other     25,580       —    
 Depreciation     8,783       —    
    Total cost of sales     34,363       —    
                 
 Gross profit     (13,363 )     —    
                 
 Operating expenses                
 Consulting fees - related party     —         48,000  
 Consulting fees     3,360       —    
 General and administrative expenses - other     12,606       25,000  
 Professional fees     28,385       —    
    Total operating expenses     44,351       73,000  
                 
 Loss from operations     (57,714 )     (73,000 )
                 
 Other (expense)                
 Interest expense     —         (240 )
                 
 Loss before income taxes     (57,714 )     (73,240 )
                 
 Income taxes     —         —    
                 
 Net loss   $ (57,714 )   $ (73,240 )
                 
 Net loss per common share - basic and diluted      *         *   
                 
 Weighted average number of common shares     10,753,504       9,308,566  
                 
 * Net loss is less than $0.01 per share.                
                 
                 
 The accompanying notes are an integral part of these financial statements.  

 

 

 

 

 

 

 

3 

 

 

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
     
         
         
      Nine Months Ended September 30,
      2020       2019  
 Sales   $ 21,000     $ —    
                 
 Cost of sales                
 Cost of sales - other     36,639       —    
 Depreciation     25,681       —    
    Total cost of sales     62,320       —    
                 
 Gross profit     (41,320 )     —    
                 
 Operating expenses                
 Consulting fees - related party     39,500       48,000  
 Consulting fees     13,860       —    
 General and administrative expenses - other     28,984       25,000  
 Professional fees     85,401       —    
    Total operating expenses     167,745       73,000  
                 
 Loss from operations     (209,065 )     (73,000 )
                 
 Other (expense)                
 Interest expense     (251 )     (240 )
                 
 Loss before income taxes     (209,316 )     (73,240 )
                 
 Income taxes     —         —    
                 
 Net loss   $ (209,316 )   $ (73,240 )
                 
 Net loss per common share - basic and diluted   $ (0.02 )      *   
                 
 Weighted average number of common shares     9,388,570       9,308,566  
                 
 * Net loss is less than $0.01 per share.                
                 
                 
 The accompanying notes are an integral part of these financial statements.  

 

 

 

4 

 

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
(Unaudited)
                             
                             
                             
    Class A Convertible Preferred   Common Shares   Additional       Total
    $0.0001 Par Value   $0.0001 Par Value   Paid-in   Accumulated   Stockholders'
    Shares   Amount   Shares   Amount   Capital   (Deficit)   Equity
 BALANCES, December 31, 2019     500,000     $ 50       8,477,505     $ 848     $ 35,388,065     $ (35,168,070 )   $ 220,893  
    Issuance of shares for services     —         —         100,000       10       12,490       —         12,500  
    Issuance of shares for conversion of debt     —         —         80,000       8       9,992       —         10,000  
    Sale of shares for cash at $0.125 per share     —         —         2,095,999       209       261,791       —         262,000  
    Net loss for the period     —         —         —         —         —         (209,316 )     (209,316 )
 BALANCES, September 30, 2020     500,000     $ 50       10,753,504     $ 1,075     $ 35,672,338     $ (35,377,386 )   $ 296,077  
                                                         
 The accompanying notes are an integral part of these financial statements.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5 

 

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
     
         
         
         
      Nine Months Ended September 30,
      2020       2019  
 OPERATING ACTIVITIES                
 Net loss   $ (209,316 )   $ (73,240 )
 Adjustment to reconcile net loss to net cash flows used                
 in operating activities                
 Depreciation     25,681       —    
 Issuance of shares for services     12,500       —    
 Changes in:                
 Accounts receivable - net     13,000       —    
 Deposits     (12,500 )     —    
 Accounts payable and accrued liabilities     (12,444 )     48,240  
 Net cash (used in) operating activities     (183,079 )     (25,000 )
                 
 INVESTING ACTIVITIES                
 Purchase of equipment     (32,426 )     —    
                 
 FINANCING ACTIVITIES                
 Funds from sale of common shares     262,000       —    
 Funds from loans, net of repayments - related party     6,730       25,000  
 Net cash provided by financing activities     268,730       25,000  
                 
 Net increase in cash     53,225       —    
 Cash at beginning of period     69,527       —    
 Cash at end of period   $ 122,752     $ —    
                 
 Supplemental Schedule of Cash Flow Information:                
 Interest paid   $ 251     $ —    
 Income taxes paid   $ —       $ —    
                 
 Supplemental Schedule of Non-Cash Flow Information                
 Issuance of shares for debt   $ 10,000     $ —    
                 
 The accompanying notes are an integral part of these financial statements.

 

 

 

 

 

 

6 
 Table of Contents 

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

September 30, 2020

 

Note 1 – Organization and History

Vyta Corp (the “Company”) was incorporated in Nevada in June 1996. On August 20, 2010, it changed its state of incorporation to Delaware and on November 5, 2010 it changed its name to Bio Lab Naturals, Inc. On August 20, 2010, the Company executed a redomicile merger with its wholly owned subsidiary Vyta Corp (Delaware), as result of the merger the Company’s corporate domicile moved from Nevada to Delaware.

 

Prior to 2011, the Company was involved in various business activities and since then the Company has been seeking a business opportunity.

 

Effective December 31, 2019, the Company entered into a Reorganization Agreement with Prime Time Live, Inc., a Colorado corporation (“PTL”), whereby PTL merged with a newly formed wholly owned subsidiary of the Company, and the subsidiary being the survivor in exchange for the Company issuing one share of its common stock for each share of PTL’s 5,500,000 issued and outstanding shares of common stock. See Note 5 – Significant Acquisition.

 

Note 2 – Summary of Significant Accounting Policies

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of Bio Lab Naturals, Inc. and its wholly owned subsidiary. All intercompany balances have been eliminated during consolidation.

 

Use of Estimates in the Preparation of Consolidated Financial Statements

 

The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates include the fair value of assets and liabilities, income taxes and the valuation allowances related to accounts receivable, deferred tax assets and contingencies.

 

Cash and Cash Equivalents

 

The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”).

Concentration of Credit Risk

 

The Company offers its services to a small number of clients. This risk of non-payment by these clients is considered minimal and the Company does not generally obtain collateral for sales. The Company continually monitors the credit standing of its clients.

 

Accounts Receivable

 

The Company records accounts receivable at net realizable value. This value includes an appropriate allowance for uncollectible accounts to reflect any loss anticipated on the accounts receivable balances and is charged to other income (expense) in the statements of operations. Management calculates this allowance based on its history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and the Company’s relationships with, and the economic status of, its clients. At September 30, 2020 and December 31, 2019, there are no allowance for uncollectible accounts.

7 
 Table of Contents 

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

September 30, 2020

 

Equipment

 

Equipment is recorded at cost and consists of video equipment. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation of video equipment is over the estimated useful life of five years using the straight-line method for consolidated financial statement purposes. At September 30, 2020 and December 31, 2019 there were capitalized costs of $177,281 and $ $160,536, respectively. Depreciation expense for the three ended September 30, 2020 and 2019 was $8,783 and $0, respectively and for the nine months ended September 30, 2020 and 2019 was $25,681 and $0, respectively. See Note 4 – Fair Value Measurements.

 

Revenue recognition

 

The Company follows the provisions of Accounting Standards Update (“ASU”) No. 2014 - 09, Revenue from Contracts with Customers (Topic 606), using the full retrospective transition method. The Company’s adoption of ASU 2014 - 09 did not have a material impact on the amount and timing of revenue recognized in its consolidated financial statements.

 

Under ASU 2014 - 09, the Company recognizes revenue when control of the promised services is transferred to clients, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.

 

The Company derives its revenues from the rendering of entertainment rental services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its contracts:

 

Identify the contract with a client;

Identify the performance obligations in the contract;

Determine the transaction price;

Allocate the transaction price to performance obligations in the contract; and

Recognize revenue as the performance obligation is satisfied.

 

Impairment of Long-Lived Assets

 

In accordance with authoritative guidance on accounting for the impairment or disposal of long-lived assets, as set forth in Topic 360 of the ASC, the Company assesses the recoverability of the carrying value of its long-lived assets when events occur that indicate an impairment in value may exist. An impairment loss is indicated if the sum of the expected undiscounted future net cash flows is less than the carrying amount of the assets. If this occurs, an impairment loss is recognized for the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets.

 

Other Comprehensive Loss

 

The Company has no material components of other comprehensive loss and accordingly, net loss is equal to comprehensive loss for the period.

 

Income Taxes

 

The Company uses the liability method of accounting for income taxes under which deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the accounting bases and the tax bases of the Company’s assets and liabilities. The deferred tax assets and liabilities are computed using enacted tax rates in effect for the year in which the temporary differences are expected to reverse.

8 
 Table of Contents 

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

September 30, 2020

 

The Company's deferred income taxes include certain future tax benefits. The Company records a valuation allowance against any portion of those deferred income tax assets when it believes, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred income tax asset will not be realized.

 

The Company has adopted ASC guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the consolidated financial statements and applies to all income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the consolidated financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. At September 30, 2020 and December 31, 2019, there were no uncertain tax positions that required accrual.

 

Goodwill

 

In accordance with generally accepted accounting principles, goodwill cannot be amortized, however, it must be tested annually for impairment. This impairment test is calculated at the reporting unit level. The goodwill impairment test has two steps. The first identifies potential impairments by comparing the fair value of a reporting unit with its book value, including goodwill. If the fair value of the reporting unit exceeds the carrying amount, goodwill is not impaired and the second step is not necessary. If the carrying value exceeds the fair value, the second step calculates the possible impairment loss by comparing the implied fair value of goodwill with the carrying amount. If the implied goodwill is less than the carrying amount, a write-down is recorded. Management tests goodwill each year for impairment, or when facts or circumstances indicate impairment has occurred.

 

Net Loss per Share

 

Basic net loss per common share of stock is calculated by dividing net loss available to common stockholders by the weighted-average number of common shares outstanding during each period. Diluted net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding, including the effect of other dilutive securities. The Company’s had no potentially dilutive securities issued as of and during the three and nine months ended September 30, 2020 and 2019.

 

Equity Based Payments

 

The Company recognizes compensation cost for equity-based awards based on estimated fair value of the award and records capitalized cost or compensation expense over the requisite service period.  

 

Off-Balance Sheet Arrangements

 

As part of its ongoing business, the Company has not participated in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities (SPEs), which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. For the period through September 30, 2020, the Company has not been involved in any unconsolidated SPE transactions.

 

Subsequent Events

 

The Company evaluates events and transactions after the balance sheet date but before the consolidated financial statements are issued.

 

 

9 
 Table of Contents 

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

September 30, 2020

 

Note 3 – Going Concern and Managements’ Plan

 

The Company’s consolidated financial statements for the three and nine months ended September 30, 2020 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Company reported a net loss for the three and nine months ended September 30, 2020 of $57,714 and $209,316, respectively and an accumulated deficit of $35,377,386 at September 30, 2020.

 

The Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern within one year after the date of the issuance of these financial statements. The future success of the Company is dependent on its ability to attract additional capital and ultimately, upon its ability to develop future profitable operations. There can be no assurance that the Company will be successful in obtaining such financing, or that it will attain positive cash flow from operations. However, management believes that actions presently being taken to raise additional capital as more fully disclosed in these financial statements provides the opportunity for the Company to continue as a going concern.

 

Note 4 – Fair Value Measurements

 

The Company applies the authoritative guidance applicable to all financial assets and liabilities required to be measured and reported on a fair value basis, as well as to non-financial assets and liabilities measured at fair value on a non-recurring basis, including impairments of long-lived assets. The fair value of an asset or liability is the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. Observable inputs are inputs that market participants would use in valuing the asset or liability based on market data obtained from sources independent of the Company. Unobservable input are inputs that reflect the Company’s assumptions of what market participants would use in valuing the asset or liability based on the information available in the circumstances.

 

Financial and non-financial assets and liabilities are classified within the valuation hierarchy based upon the lowest level of input that is significant to the fair value measurement. The Company’s policy is to recognize transfers in and out of the fair value hierarchy as of the end of the reporting period in which the event or change in circumstances caused the transfer. The Company has consistently applied the valuation techniques discussed below in all periods presented. The hierarchy is organized into three levels based on the reliability of the inputs as follows:

 

Level 1: Quoted prices in active markets for identical assets or liabilities; or

Level 2: Quoted prices in active markets for similar assets and liabilities and inputs, quoted prices for identical or similar assets or liabilities in markets that are not active and model-derived valuations whose inputs or significant value drivers are observable; or

Level 3: Unobservable pricing inputs in which there is little or no market data, which requires the reporting entity to develop its own assumptions.

 

The following table presents the Company’s non-financial assets and liabilities that were measured at fair value on a non-recurring basis at December 31, 2019 by level within the fair value hierarchy:

 

Description   Level 1   Level 2   Level 3   Total
        Assets                                   
   Equipment      $ —       $ —       $ 160,536     $ 160,536  
   Goodwill      $ —       $ —       $ 1,429,107     $ 1,429,107  

 

Effective December 31 2019, the Company’s equipment was tested under ASC 360 as to its recoverability to determine if impairment is required under the accounting guidance. The Company used Level 3 inputs to measure the fair value of the assets. As such, there was no impairment.

10 
 Table of Contents 

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

September 30, 2020

 

Effective December 31, 2019, the Company acquired Prime Time Live Inc. and as a result realized goodwill in the amount of $1,429,107. Thus, due to the significance of this event, goodwill was tested under ASC 360 as to its recoverability. Therefore, goodwill is recorded at fair value if impairment is required under the accounting guidance. The Company used Level 3 inputs to measure the fair value of the asset and management determined that there were no future undiscounted cash flows associated with goodwill. As such, the Company’s goodwill was fully impaired at December 31, 2019 in the amount of $1,429,107.

 

Note 5 – Significant Acquisition

 

Effective December 31, 2019, the Company entered into a Reorganization Agreement with Prime Time Live, Inc., a Colorado corporation whereby PTL merged with a newly formed wholly owned subsidiary of the Company, and the subsidiary being the survivor in exchange for the Company issuing one share of its common stock for each share of PTL’s 5,500,000 issued and outstanding shares of common stock valued at $0.30 per share, based upon the stock price on the OTC markets at December 31, 2019, or a total value of $1,650,000.

 

The following table presents the allocation of the consideration given to the assets acquired and liabilities assumed, based on their fair values at December 31, 2019:

 

    Consideration Given    
Shares of common stock   $ 1,650,000  
         
Total purchase price   $ 1,650,000  
         
     Allocation of Consideration Given        
Cash   $ 69,527  
Accounts receivable, net     13,000  
Equipment     160,536  
Goodwill     1,429,107  
         
Total assets     1,672,170  
         
Current liabilities     22,170  
         
Net assets acquired   $ 1,650,000  

 

Note 6 – Debt

 

Convertible Promissory Note

 

An affiliate of an officer of the Company, loaned the Company $14,200 in exchange for an unsecured convertible promissory note that included interest at the rate of six percent (6%) per annum on the unpaid principal balance with any accrued and unpaid interest due on or before December 31, 2020 (the “Note”). The Note allowed for the note holder to convert, at their discretion, any accrued and unpaid interest and principal balance due on the Note in whole or in part into shares of the Company’s common stock at a conversion price of $0.125 per share. On June 12, 2020, the note holder converted $10,000 of the Note into 80,000 shares of the Company’s common stock and on July 1, 2020 the Company repaid $4,200 in principal on the Note plus $251 in interest. At September 30, 2020, the Note was paid in full. See Note 9 - Related Party Transactions.

 

11 
 Table of Contents 

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

September 30, 2020

 

Note 7 – Stockholders’ Equity

 

Preferred Shares

 

Class A Convertible

 

At September 30, 2020, there are a total of 500,000 shares of Class A Convertible shares of preferred stock (“Class A”) issued and outstanding. The Class A shares provide that when voting as a single class, the shares shall have the votes and the voting power at all times to be at least 60% of the voting power of the Company. Further, the holders of the Class A shares at their discretion and subject to a change of control and to the qualification by application to either NASQAD or NYSE Emerging Markets, can convert their one share of Class A into two shares of the Company’s common stock, subject to adjustment. In addition, the holder of the shares of Class A is entitled to a liquidation preference of the Company senior to all other securities of the Company.

 

Common Shares

 

The Company’s capital stock at September 30, 2020 consists of 200,000,000 authorized shares of $0.0001 par value common stock. At September 30, 2020, there are a total of 10,753,504 shares of common stock issued and outstanding.

 

During the nine months ended September 30, 2020, the Company sold 2,095,999 of its common stock as part of a private placement for $262,000 in cash or $0.125 per share, issued 100,000 shares of its common for services rendered in the amount of $12,500 and issued 80,000 shares of its common stock to convert debt in the amount of $10,000. See Note 9 – Related Party Transactions.

 

Note 8 – Equity Based Payments

 

The Company accounts for equity-based payment accruals under authoritative guidance as set forth in the Topics of the ASC. The guidance requires all equity-based payments to employees and non-employees, including grants of employee and non-employee stock options and warrants, to be recognized in the consolidated financial statements based at their fair values.

 

2014 Stock Incentive Plan

 

Effective January 15, 2020, the Company’s adopted its 2020 Stock Option and Award Plan (the “2020 Stock Incentive Plan”). Under the 2020 Stock Incentive Plan, the Board of Directors may grant options or purchase rights to purchase common stock to officers, employees, and other persons who provide services to the Company or any related company. The participants to whom awards are granted, the type of awards granted, the number of shares covered for each award, and the purchase price, conditions and other terms of each award are determined by the Board of Directors, except that the term of the options shall not exceed 10 years. A total of 2 million shares of the Company’s common stock are subject to the 2020 Stock Incentive Plan. The shares issued for the 2020 Stock Incentive Plan may be either treasury or authorized and unissued shares. During the three and nine months ended September 30, 2020, the Company granted no options under the 2020 Stock Incentive Plan.

 

Note 9 – Related Party Transactions

 

Due to Related Parties

 

During the three months ended September 30, 2020, the Company repaid an affiliate of one of its officers $4,200 in principal plus $251 in interest toward an unsecured convertible promissory note.

 

12 
 Table of Contents 

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

September 30, 2020

 

During the three months ended September 30, 2020, the Company repaid an affiliate of one of its officers $3,270 on an unsecured loan and at September 30, 2020 owes $0.

 

During the nine months ended September 30, 2020, the Company repaid an affiliate of one of its officers $10,000 toward an unsecured convertible promissory note by issuing 80,000 shares of its common stock value at $0.125 per share.

 

Equity for Services

 

During the nine months ended September 30, 2020, the Company issued 100,000 shares of its common stock to two of its board members valued at $12,500 in exchange for services and expensed such services as consulting fees in the statement of operations.

 

Consulting Fees

 

During the nine months ended September 30, 2020 and 2019, the Company incurred consulting fees in the amount of $39,500 and $48,000, respectively to an officer, an officer of one of its affiliates and a promoter.

 

Note 9 – Subsequent Events

 

The Company’s Form S-1 Registration Statement filed with the Securities and Exchange Commission became effective on October 16, 2020.

 

13 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

Forward-Looking Statements and Associated Risks.

 

This Form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, words such as “may,” “will, “expect,” “believe,” “anticipate,” “estimate,” “continue” or comparable terminology are intended to identify forward-looking statements. These statements by their nature involve substantial risks and uncertainties, and actual results may differ materially depending on a variety of factors, many of which are not within our control. These factors include but are not limited to economic conditions generally and in the industries in which we may participate; competition within our chosen industry, including competition from much larger competitors; technological advances and failure to successfully develop business relationships.

 

Based on our financial history since inception, our auditor has expressed substantial doubt as to our ability to continue as a going concern. As reflected in the accompanying financial statements, as of September 30, 2020, we had an accumulated deficit totaling $35,377,386. This raises substantial doubts about our ability to continue as a going concern.

 

Our plan of operations for the next 12 months is as follows:

 

The Company has been continuing its business and has experienced sales during the three months ended September 30, 2020 of $21,000. Management has now been able to reconnect with event services business relationships as a result of the impact from COVID-19 lessening and the normal demand for the event services business. Therefore, the Company now expects, without any new or additional steps, additional revenues to be generated during the fourth quarter of 2020 and continued operational status.

 

4th Quarter 2020  Marketing and Operations $50,041
     
1st Quarter 2021  Marketing and Operations $18,559
     
2nd Quarter 2021 Marketing and Operations $70,290
     
3rd Quarter 2021 Marketing and Operations $82,694

 

Results of HISTORICAL Operations

 

For the Three Months Ended September 30, 2020 Compared to the Three Months Ended September 30, 2020

 

During the three months ended September 30, 2020 and 2019 we recognized total revenues of $21,000. The Company expects to generate revenues in the fourth quarter of 2020 and for the next 12 months.

 

Gross profit loss for the three months ended September 30, 2020 was $(13,363) compared to $0 for three months ended September 30, 2019. The increase in gross profit loss of $13,363 pertained primarily to increase in cost of sales of $34,363 offsetting related revenues of $21,000.

 

During the three months ended September 30, 2020, we recognized $44,351 in operating expenses compared to $73,000 for the three months ended September 30, 2019. The change results primarily from a decrease in related party consulting fees and general and administrative expenses for the current period.

 

14 

 

For the Nine Months Ended September 30, 2020 Compared to the Nine Months Ended September 30, 2019

 

During the nine months ended September 30, 2020 and 2019 we recognized total revenues of $21,000 and $0, respectively. The Company expects to generate revenues in the fourth quarter of 2020 and for the next 12 months.

 

Gross profit loss for the nine months ended September 30, 2020 was $(41,320) compared to $0 for the nine months ended September 30, 2019. The increase in gross profit loss of $41,320 pertained primarily to increase in cost of sales of $62,320 offsetting related revenues of $21,000.

 

During the nine months ended September 30, 2020, we recognized $167,745 in operating expenses compared to 73,000 for the nine months ended September 30, 2019. The change of $94,745 results primarily from an increase in consulting and professional fees for the current period due to the expenses associated with the filing of a Registration Statement with the SEC, filings with the OTC Markets and related audits.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Financing Activities

 

During the nine months ended September 30, 2020, the Company sold 2,095,999 of its common stock as part of a private placement for $262,000 and received loans from related parties, net of repayments, in the amount of $6,730.

 

Investing Activities

 

During the nine months ended September 30, 2020, the Company purchased additional event screens in the amount of $32,426.

 

Operating Activities

 

During the nine months ended September 30, 2020, the Company used cash flows from operational activities of $183,079 that was adjusted by non-cash items of: deprecation in the amount of $25,681 and the issuance of shares for services in the amount of $12,500.

 

Convertible Promissory Note

 

An affiliate of an officer of the Company, loaned the Company $14,200 in exchange for an unsecured convertible promissory note that included interest at the rate of six percent (6%) per annum on the unpaid principal balance with any accrued and unpaid interest due on or before December 31, 2020 (the “Note”). The Note allowed for the note holder to convert, at their discretion, any accrued and unpaid interest and principal balance due on the Note in whole or in part into shares of the Company’s common stock at a conversion price of $0.125 per share. On June 12, 2020, the note holder converted $10,000 of the Note into 80,000 shares of the Company’s common stock and on July 1, 2020 the Company repaid $4,200 in principal on the Note plus $251 in interest. At September 30, 2020, the Note was paid in full. See Note 9 - Related Party Transactions.

 

In order for us to continue as a going concern, we will need to obtain additional debt or equity financing and look for companies with cash flow positive operations that we can acquire. There can be no assurance that we will be able to secure additional debt or equity financing, that we will be able to acquire cash flow positive operations, or that, if we are successful in any of those actions, those actions will produce adequate cash flow to enable us to meet all our future obligations. Most of our existing financing arrangements are short-term. If we are unable to obtain additional debt or equity financing, we may be required to significantly reduce or cease operations.

 

 

 

15 

Going Concern

 

We have approximately $115,000 in cash as of October 30, 2020 and have incurred operating losses and limited cash flows from operations since inception. As of September 30, 2020, we had accumulated deficit of $(35,377,386) and we will require additional working capital to fund operations through 2020 and beyond. These factors, among others, raise substantial doubt about our ability to continue as a going concern. Our financial statements included in this Form 10-Q do not include any adjustments related to recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern. The audited financial statements included in the Company’s recent Registration Statement on Form S-1 have been prepared assuming that we will continue as a going concern and do not include any adjustments that might result if we cease to continue as a going concern.

 

Based on our financial history since inception, in their report on the financial statements for the period ended December 31, 2019, our independent registered public accounting firm has expressed substantial doubt as to our ability to continue as a going concern. There is no assurance that any revenue will be realized in the future.

 

There can be no assurance that we will have adequate capital resources to fund planned operations or that any additional funds will be available to us when needed or at all, or, if available, will be available on favorable terms or in amounts required by us. If we are unable to obtain adequate capital resources to fund operations, we may be required to delay, scale back or eliminate some or all of our operations, which may have a material adverse effect on our business, results of operations and ability to operate as a going concern.

 

Short Term

 

On a short-term basis, we have not generated revenues sufficient to cover our growth-oriented operations plan. Based on prior history, we may continue to incur losses until such a time that our revenues are sufficient to cover our operating expenses and growth-oriented operations plan. As a result, we may need additional capital in the form of equity or loans, none of which is committed as of this filing.

 

Capital Resources

 

We have only common stock as our capital resource, and our assets, cash and receivables.

 

We have no material commitments for capital expenditures within the next year, however, as operations are expanded substantial capital will be needed to pay for expansion and working capital.

 

Need for Additional Financing

 

We have limited funds, and such funds may not be adequate to carry out our business plan in the event production industry. Our ultimate success depends upon our ability to raise additional capital. We are investigating the availability, sources, and terms that might govern the acquisition of additional capital.

 

We have no commitment at this time for additional capital. If we need additional capital, we have no assurance that funds will be available from any source or, if available, that they can be obtained on terms acceptable to us. If not available, our operations will be limited to those that can be financed with our existing capital.

 

Off Balance Sheet Arrangements

 

None

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

16 

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time period specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is accumulated and communicated to management including our principal executive officer/principal financial officer as appropriate, to allow timely decisions regarding required disclosure.

 

Management has carried out an evaluation of the effectiveness of the design and operation of our Company’s disclosure controls and procedures. Due to the lack of personnel and outside directors, management acknowledges that there are deficiencies in these controls and procedures. The Company anticipates that with further resources, the Company will expand both management and the board of directors with additional officers and independent directors in order to provide sufficient disclosure controls and procedures.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) or 15d-15(f)) during the quarter ended September 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

In light of the current COVID-19 global pandemic, the Company included the following risk factors below in the Registration Statement declared effective by the Securities and Exchange Commission on October 16, 2020. The Company additionally will add the subsequent risk factors going forward until further notice.

 

COVID-19 EFFECTS ON THE ECONOMY MAY NEGATIVELY AFFECT OUR COMPANY BUSINESS.

 

In December 2019, COVID-19 emerged and has subsequently spread worldwide. The World Health Organization has declared COVID-19 a pandemic resulting in federal, state and local governments and private entities mandating various restrictions, including travel restrictions, restrictions on public gatherings, stay at home orders and advisories and quarantining of people who may have been exposed to the virus.

 

As the COVID-19 pandemic is complex and rapidly evolving, the Company's business has been and will be negatively affected for a sustained time frame. At this point, we cannot reasonably estimate the duration and severity of this pandemic, which could have a material adverse impact on our business, results of operations, financial position and cash flows.

 

The restrictions on crowds, gatherings, crowd sizes and travel have absolutely negatively impacted our business which relies upon social, sports and entertainment event gatherings to service. COVID-19 has impacted our revenue by 100% for approximately the last six months and has recently begun some recommencement of our services.

 

17 

 

The continuation of COVID-19 related restriction or impacts on social, sports and entertainment gatherings has and will impact our revenues negatively and such lack of business raises substantial doubt about our ability to grow, maintain, and expand our business and generate revenues sufficient to sustain our operations as planned.

 

Other than as provided above, there are no material changes to risk factors as previously disclosed in the Company’s Registration Statement on Form S-1 declared effective by the Securities and Exchange Commission on October 16, 2020. 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURE

 

Not Applicable.

 

ITEM 5. OTHER INFORMATION

 

Not Applicable.

 

ITEM 6. EXHIBITS

 

Exhibits. The following is a complete list of exhibits filed as part of this Form 10-Q. Exhibit numbers correspond to the numbers in the Exhibit Table of Item 601 of Regulation S-K.

 

31.1 Certification of Chief Executive Officer Pursuant to Rule 13a–14(a) or 15d-14(a) of the Securities Exchange Act of 1934
31.2 Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934
32.1 Certification of Chief Executive Officer under Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2 Certification of Chief Financial Officer under Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS XBRL Instance Document (1)
101.SCH XBRL Taxonomy Extension Schema Document (1)
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document (1)
101.DEF XBRL Taxonomy Extension Definition Linkbase Document (1)
101.LAB XBRL Taxonomy Extension Label Linkbase Document (1)
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document (1)

 

  (1) Pursuant to Rule 406T of Regulation S-T, this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

 

18 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  BIO LAB NATURALS, INC.
  (Registrant)
     
Dated: November 4, 2020 By: /s/ W. Edward Nichols
    W. Edward Nichols
    (Chief Executive Officer, Principal Executive
    Officer)
     
Dated: November 4, 2020 By: /s/ Darrell Avey
    Darrell Avey
    (Chief Financial Officer, Principal Accounting
    Officer)
     

  

 

19 

 

  

 

 

 EX-31.1 2 ex31_1.htm

EXHIBIT 31.1 

 

CERTIFICATION OF PERIODIC REPORT

 

I, W. Edward Nichols, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Bio Lab Naturals, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s 4th quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 4, 2020

 

/s/ W. Edward Nichols  
W. Edward Nichols  
(Chief Executive Officer and Principal Executive Officer)  
 EX-31.2 3 ex31_2.htm

EXHIBIT 31.2 

 

CERTIFICATION OF PERIODIC REPORT

 

I, Darrell Avey, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Bio Lab Naturals, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s 4th quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 4, 2020

 

/s/ Darrell Avey  
Darrell Avey  
(Chief Financial Officer and Principal Accounting Officer)  

 

 EX-32.1 4 ex32_1.htm

 

EXHIBIT 32.1

 

CERTIFICATION OF DISCLOSURE PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Bio Lab Naturals, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) I, W. Edward Nichols, Chief Executive Officer and Principal Executive Officer of the Company, certify, pursuant to 18 USC Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: November 4, 2020

 

/s/ W. Edward Nichols  
W. Edward Nichols  
(Chief Executive Officer and Principal Executive Officer)  

 

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 EX-32.2 5 ex32_2.htm

 

EXHIBIT 32.2

 

CERTIFICATION OF DISCLOSURE PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Bio Lab Naturals, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) I, Darrell Avey, Chief Financial Officer and Principal Accounting Officer of the Company, certify, pursuant to 18 USC Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: November 4, 2020

 

/s/ Darrell Avey  
Darrell Avey  
(Chief Financial Officer and Principal Accounting Officer)  

 

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 

 EX-101.INS 6 blab-20200930.xml 0001803977 2020-01-01 2020-09-30 0001803977 2020-09-30 0001803977 2019-12-31 0001803977 2020-07-01 2020-09-30 0001803977 2019-07-01 2019-09-30 0001803977 2019-01-01 2019-09-30 0001803977 2018-12-31 0001803977 2019-09-30 0001803977 blab:ConvertiblePreferredStockSeriesAMember 2020-01-01 2020-09-30 0001803977 blab:ConvertiblePreferredStockSeriesAMember 2019-12-31 0001803977 blab:ConvertiblePreferredStockSeriesAMember 2020-09-30 0001803977 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001803977 us-gaap:CommonStockMember 2019-12-31 0001803977 us-gaap:CommonStockMember 2020-09-30 0001803977 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001803977 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001803977 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001803977 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001803977 us-gaap:RetainedEarningsMember 2019-12-31 0001803977 us-gaap:RetainedEarningsMember 2020-09-30 0001803977 blab:ConvertiblePreferredStockClassAMember 2019-12-31 0001803977 blab:ConvertiblePreferredStockClassAMember 2020-09-30 0001803977 blab:AffiliateOfficersMember blab:UnsecuredConvertiblePromissoryNoteMember 2020-07-01 2020-09-30 0001803977 blab:AffiliateOfficersMember blab:UnsecuredConvertiblePromissoryNoteMember 2020-09-30 0001803977 blab:BoardMembersMember 2020-07-01 2020-09-30 0001803977 blab:OfficersAndAffiliateMember 2020-01-01 2020-09-30 0001803977 blab:ConvertiblePreferredStockClassAMember 2020-01-01 2020-09-30 0001803977 us-gaap:PrivatePlacementMember 2020-09-30 0001803977 blab:AnAffiliateOfAnOfficerOfCompanyMember blab:UnsecuredConvertiblePromissoryNoteMember 2020-09-30 0001803977 blab:PrimeTimeLiveIncMember 2019-12-01 2019-12-31 0001803977 blab:PrimeTimeLiveIncMember 2019-12-31 0001803977 us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001803977 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0001803977 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001803977 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0001803977 blab:AnAffiliateOfAnOfficerOfCompanyMember blab:UnsecuredConvertiblePromissoryNoteMember 2020-07-02 0001803977 2020-10-30 0001803977 us-gaap:PrivatePlacementMember 2020-01-01 2020-09-30 0001803977 blab:StockIncentivePlan2020Member 2020-01-01 2020-09-30 0001803977 blab:AffiliateOfficersMember blab:UnsecuredConvertiblePromissoryNoteMember 2020-01-01 2020-09-30 0001803977 blab:OfficersAndAffiliateMember 2019-01-01 2019-09-30 0001803977 blab:AnAffiliateOfAnOfficerOfCompanyMember blab:UnsecuredConvertiblePromissoryNoteMember 2020-06-01 2020-06-12 0001803977 blab:AffiliateOfficersMember 2020-09-30 0001803977 blab:AffiliateOfficersMember 2020-07-01 2020-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 10-Q false 2020-09-30 Q3 2020 --12-31 0001803977 Yes Non-accelerated Filer true true false 10753504 500000 500000 8477505 10753504 296077 220893 50 50 848 1075 35388065 35672338 -35168070 -35377386 true 100000 100000 100000 12500 10 12490 12500 12500 10000 8 9992 80000 -209316 -57714 -73240 -73240 -209316 2095999 2095999 262000 209 261791 262000 0.125 0.125 13000 12500 135252 82527 177281 160536 312533 243063 16456 18900 3270 16456 22170 16456 22170 50 50 1075 848 1650000 -35377386 -35168070 312533 243063 25681 25681 0.0001 0.0001 0.04 0.04 5000000 5000000 0.0001 0.0001 0.30 200000000 200000000 10753504 8477505 5500000 10753504 8477505 5500000 21000 21000 25681 8783 62320 34363 36639 25580 -41320 -13363 28984 12606 25000 25000 85401 28385 167745 44351 73000 73000 -209065 -57714 -73000 -73000 -209316 -57714 -73240 -73240 -0.02 9388570 10753504 9308566 9308566 13860 3360 39500 48000 48000 39500 48000 80000 80000 80000 10000 10000 0.125 0.125 14200 251 4200 0.06 1650000 1650000 69527 13000 160536 1429107 1672170 22170 1650000 1429107 1429107 160536 160536 177281 160536 false 84-2288662 DE (720) 273-0433 Yes 35672338 35388065 500000 500000 500000 500000 -183079 -25000 -12444 48240 12500 -13000 -32426 262000 122752 69527 53225 268730 25000 6730 25000 10000 251 240 240 The Class A shares provide that when voting as a single class, the shares shall have the votes and the voting power at all times to be at least 60% of the voting power of the Company. P10Y 2000000 4200 10000 3270 0 251 251 333-239640 BIO LAB NATURALS, INC. 7400 E. Crestline Circle Suite 130 false 80111 CO Greenwood Village <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b><a name="a_007"></a>Note 1 &#8211; Organization and History &#9;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Vyta Corp (the &#8220;Company&#8221;) was incorporated in Nevada in June 1996. On August 20, 2010, it changed its state of incorporation to Delaware and on November 5, 2010 it changed its name to Bio Lab Naturals, Inc. On August 20, 2010, the Company executed a redomicile merger with its wholly owned subsidiary Vyta Corp (Delaware), as result of the merger the Company&#8217;s corporate domicile moved from Nevada to Delaware.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prior to 2011, the Company was involved in various business activities and since then the Company has been seeking a business opportunity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective December 31, 2019, the Company entered into a Reorganization Agreement with Prime Time Live, Inc., a Colorado corporation (&#8220;PTL&#8221;), whereby PTL merged with a newly formed wholly owned subsidiary of the Company, and the subsidiary being the survivor in exchange for the Company issuing one share of its common stock for each share of PTL&#8217;s 5,500,000 issued and outstanding shares of common stock. See Note 5 &#8211; Significant Acquisition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2 &#8211; Summary of Significant Accounting Policies </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Principles of Consolidation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements include the accounts of Bio Lab Naturals, Inc. and its wholly owned subsidiary. All intercompany balances have been eliminated during consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates in the Preparation of Consolidated Financial Statements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates include the fair value of assets and liabilities, income taxes and the valuation allowances related to accounts receivable, deferred tax assets and contingencies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash and Cash Equivalents</u>&#9;</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 0 10.85pt; text-align: justify">The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Concentration of Credit Risk </u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company offers its services to a small number of clients. This risk of non-payment by these clients is considered minimal and the Company does not generally obtain collateral for sales. The Company continually monitors the credit standing of its clients.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts Receivable</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records accounts receivable at net realizable value. This value includes an appropriate allowance for uncollectible accounts to reflect any loss anticipated on the accounts receivable balances and is charged to other income (expense) in the statements of operations. Management calculates this allowance based on its history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and the Company&#8217;s relationships with, and the economic status of, its clients. At September 30, 2020 and December 31, 2019, there are no allowance for uncollectible accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Equipment</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Equipment is recorded at cost and consists of video equipment. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation of video equipment is over the estimated useful life of five years using the straight-line method for consolidated financial statement purposes. At September 30, 2020 and December 31, 2019 there were capitalized costs of $177,281 and $ $160,536, respectively. Depreciation expense for the three ended September 30, 2020 and 2019 was $8,783 and $0, respectively and for the nine months ended September 30, 2020 and 2019 was $25,681 and $0, respectively. See Note 4 &#8211; Fair Value Measurements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue recognition </u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows the provisions of Accounting Standards Update (&#8220;ASU&#8221;) No.&#160;2014&#160;-&#160;09,&#160;<i>Revenue from Contracts with Customers (Topic&#160;606), </i>using the full retrospective transition method. The Company&#8217;s adoption of ASU&#160;2014&#160;-&#160;09&#160;did not have a material impact on the amount and timing of revenue recognized in its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under ASU&#160;2014&#160;-&#160;09, the Company recognizes revenue when control of the promised services is transferred to clients, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company derives its revenues from the rendering of entertainment rental services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its contracts:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Identify the contract with a client;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Identify the performance obligations in the contract;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Determine the transaction price;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Allocate the transaction price to performance obligations in the contract; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Recognize revenue as the performance obligation is satisfied.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Impairment of Long-Lived Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with authoritative guidance on accounting for the impairment or disposal of long-lived assets, as set forth in Topic 360 of the ASC, the Company assesses the recoverability of the carrying value of its long-lived assets when events occur that indicate an impairment in value may exist. An impairment loss is indicated if the sum of the expected undiscounted future net cash flows is less than the carrying amount of the assets. If this occurs, an impairment loss is recognized for the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Other Comprehensive Loss</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has no material components of other comprehensive loss and accordingly, net loss is equal to comprehensive loss for the period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income Taxes</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company uses the liability method of accounting for income taxes under which deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the accounting bases and the tax bases of the Company&#8217;s assets and liabilities. The deferred tax assets and liabilities are computed using enacted tax rates in effect for the year in which the temporary differences are expected to reverse.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's deferred income taxes include certain future tax benefits. The Company records a valuation allowance against any portion of those deferred income tax assets when it believes, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred income tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has adopted ASC guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the consolidated financial statements and applies to all income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the consolidated financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. At September 30, 2020 and December 31, 2019, there were no uncertain tax positions that required accrual.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Goodwill</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with generally accepted accounting principles, goodwill cannot be amortized, however, it must be tested annually for impairment. This impairment test is calculated at the reporting unit level. The goodwill impairment test has two steps. The first identifies potential impairments by comparing the fair value of a reporting unit with its book value, including goodwill. If the fair value of the reporting unit exceeds the carrying amount, goodwill is not impaired and the second step is not necessary. If the carrying value exceeds the fair value, the second step calculates the possible impairment loss by comparing the implied fair value of goodwill with the carrying amount. If the implied goodwill is less than the carrying amount, a write-down is recorded. Management tests goodwill each year for impairment, or when facts or circumstances indicate impairment has occurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Net Loss per Share</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic net loss per common share of stock is calculated by dividing net loss available to common stockholders by the weighted-average number of common shares outstanding during each period. Diluted net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding, including the effect of other dilutive securities. The Company&#8217;s had no potentially dilutive securities issued as of and during the three and nine months ended September 30, 2020 and 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Equity Based Payments</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes compensation cost for equity-based awards based on estimated fair value of the award and records capitalized cost or compensation expense over the requisite service period. &#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Off-Balance Sheet Arrangements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As part of its ongoing business, the Company has not participated in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities (SPEs), which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. For the period through September 30,&#160;2020, the Company has not been involved in any unconsolidated SPE transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Subsequent Events</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates events and transactions after the balance sheet date but before the consolidated financial statements are issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3 &#8211; Going Concern and Managements&#8217; Plan</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s consolidated financial statements for the three and nine months ended September 30, 2020 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Company reported a net loss for the three and nine months ended September 30, 2020 of $57,714 and $209,316, respectively and an accumulated deficit of $35,377,386 at September 30, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s significant operating losses raise substantial doubt about its ability to continue as a going concern within one year after the date of the issuance of these financial statements. The future success of the Company is dependent on its ability to attract additional capital and ultimately, upon its ability to develop future profitable operations. There can be no assurance that the Company will be successful in obtaining such financing, or that it will attain positive cash flow from operations. However, management believes that actions presently being taken to raise additional capital as more fully disclosed in these financial statements provides the opportunity for the Company to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4 &#8211; Fair Value Measurements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies the authoritative guidance applicable to all financial assets and liabilities required to be measured and reported on a fair value basis, as well as to non-financial assets and liabilities measured at fair value on a non-recurring basis, including impairments of long-lived assets. The fair value of an asset or liability is the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. Observable inputs are inputs that market participants would use in valuing the asset or liability based on market data obtained from sources independent of the Company. Unobservable input are inputs that reflect the Company&#8217;s assumptions of what market participants would use in valuing the asset or liability based on the information available in the circumstances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial and non-financial assets and liabilities are classified within the valuation hierarchy based upon the lowest level of input that is significant to the fair value measurement. The Company&#8217;s policy is to recognize transfers in and out of the fair value hierarchy as of the end of the reporting period in which the event or change in circumstances caused the transfer. The Company has consistently applied the valuation techniques discussed below in all periods presented. The hierarchy is organized into three levels based on the reliability of the inputs as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Level 1: Quoted prices in active markets for identical assets or liabilities; or</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 2: Quoted prices in active markets for similar assets and liabilities and inputs, quoted prices for identical or similar assets or liabilities in markets that are not active and model-derived valuations whose inputs or significant value drivers are observable; or</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 3: Unobservable pricing inputs in which there is little or no market data, which requires the reporting entity to develop its own assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the Company&#8217;s non-financial assets and liabilities that were measured at fair value on a non-recurring basis at December 31, 2019 by level within the fair value hierarchy:</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Description</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Total</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;&#160;&#160;&#160;&#160;&#160;Assets&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 1%">&#160;</td> <td style="width: 20%">&#160;Equipment&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">&#8212;&#160;&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">&#8212;&#160;&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">160,536</td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">160,536</td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;Goodwill&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>$</td> <td style="text-align: right">&#8212;&#160;&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>$</td> <td style="text-align: right">&#8212;&#160;&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>$</td> <td style="text-align: right">1,429,107</td> <td>&#160;</td> <td>&#160;</td> <td>$</td> <td style="text-align: right">1,429,107</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective December 31 2019, the Company&#8217;s equipment was tested under ASC 360 as to its recoverability to determine if impairment is required under the accounting guidance. The Company used Level 3 inputs to measure the fair value of the assets. As such, there was no impairment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective December 31, 2019, the Company acquired Prime Time Live Inc. and as a result realized goodwill in the amount of $1,429,107. Thus, due to the significance of this event, goodwill was tested under ASC 360 as to its recoverability. Therefore, goodwill is recorded at fair value if impairment is required under the accounting guidance. The Company used Level 3 inputs to measure the fair value of the asset and management determined that there were no future undiscounted cash flows associated with goodwill. As such, the Company&#8217;s goodwill was fully impaired at December 31, 2019 in the amount of $1,429,107.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5 &#8211; Significant Acquisition</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective December 31, 2019, the Company entered into a Reorganization Agreement with Prime Time Live, Inc., a Colorado corporation whereby PTL merged with a newly formed wholly owned subsidiary of the Company, and the subsidiary being the survivor in exchange for the Company issuing one share of its common stock for each share of PTL&#8217;s 5,500,000 issued and outstanding shares of common stock valued at $0.30 per share, based upon the stock price on the OTC markets at December 31, 2019, or a total value of $1,650,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the allocation of the consideration given to the assets acquired and liabilities assumed, based on their fair values at December 31, 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><i>&#160;&#160;&#160;&#160;Consideration Given</i></td> <td>&#160;</td> <td colspan="3">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 71%; padding-bottom: 1pt">Shares of common stock</td> <td style="width: 10%; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; width: 1%">$</td> <td style="border-bottom: black 1pt solid; width: 17%; text-align: right">1,650,000</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: center">Total purchase price</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,650,000</td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><i>&#160;&#160;&#160;&#160;&#160;Allocation of Consideration Given</i></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Cash</td> <td>&#160;</td> <td>$</td> <td style="text-align: right">69,527</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Accounts receivable, net</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">13,000</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Equipment</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">160,536</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt">Goodwill</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">1,429,107</td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center">Total assets</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">1,672,170</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt">Current liabilities</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">22,170</td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: center">Net assets acquired</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,650,000</td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 6 &#8211; Debt</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Convertible Promissory Note</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An affiliate of an officer of the Company, loaned the Company $14,200 in exchange for an unsecured convertible promissory note that included interest at the rate of six percent (6%) per annum on the unpaid principal balance with any accrued and unpaid interest due on or before December 31, 2020 (the &#8220;Note&#8221;). The Note allowed for the note holder to convert, at their discretion, any accrued and unpaid interest and principal balance due on the Note in whole or in part into shares of the Company&#8217;s common stock at a conversion price of $0.125 per share. On June 12, 2020, the note holder converted $10,000 of the Note into 80,000 shares of the Company&#8217;s common stock and on July 1, 2020 the Company repaid $4,200 in principal on the Note plus $251 in interest. At September 30, 2020, the Note was paid in full. See Note 9 - Related Party Transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 7 &#8211; Stockholders&#8217; Equity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Preferred Shares</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Class A Convertible</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At September 30, 2020, there are a total of 500,000 shares of Class A Convertible shares of preferred stock (&#8220;Class A&#8221;) issued and outstanding. The Class A shares provide that when voting as a single class, the shares shall have the votes and the voting power at all times to be at least 60% of the voting power of the Company. Further, the holders of the Class A shares at their discretion and subject to a change of control and to the qualification by application to either NASQAD or NYSE Emerging Markets, can convert their one share of Class A into two shares of the Company&#8217;s common stock, subject to adjustment. In addition, the holder of the shares of Class A is entitled to a liquidation preference of the Company senior to all other securities of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common Shares</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s capital stock at September 30, 2020 consists of 200,000,000 authorized shares of $0.0001 par value common stock. At September 30, 2020, there are a total of 10,753,504 shares of common stock issued and outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended September 30, 2020, the Company sold 2,095,999 of its common stock as part of a private placement for $262,000 in cash or $0.125 per share, issued 100,000 shares of its common for services rendered in the amount of $12,500 and issued 80,000 shares of its common stock to convert debt in the amount of $10,000. See Note 9 &#8211; Related Party Transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 8 &#8211; Equity Based Payments</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for equity-based payment accruals under authoritative guidance as set forth in the Topics of the ASC. The guidance requires all equity-based payments to employees and non-employees, including grants of employee and non-employee stock options and warrants, to be recognized in the consolidated financial statements based at their fair values.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>2014 Stock Incentive Plan</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective January&#160;15, 2020, the Company&#8217;s adopted its 2020 Stock Option and Award Plan (the &#8220;2020 Stock Incentive Plan&#8221;). Under the 2020 Stock Incentive Plan, the Board of Directors may grant options or purchase rights to purchase common stock to officers, employees, and other persons who provide services to the Company or any related company. The participants to whom awards are granted, the type of awards granted, the number of shares covered for each award, and the purchase price, conditions and other terms of each award are determined by the Board of Directors, except that the term of the options shall not exceed 10 years. A total of 2 million shares of the Company&#8217;s common stock are subject to the 2020 Stock Incentive Plan. The shares issued for the 2020 Stock Incentive Plan may be either treasury or authorized and unissued shares. During the three and nine months ended September 30, 2020, the Company granted no options under the 2020 Stock Incentive Plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 9 &#8211; Related Party Transactions</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Due to Related Parties</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended September 30, 2020, the Company repaid an affiliate of one of its officers $4,200 in principal plus $251 in interest toward an unsecured convertible promissory note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended September 30, 2020, the Company repaid an affiliate of one of its officers $3,270 on an unsecured loan and at September 30, 2020 owes $0.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended September 30, 2020, the Company repaid an affiliate of one of its officers $10,000 toward an unsecured convertible promissory note by issuing 80,000 shares of its common stock value at $0.125 per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Equity for Services</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended September 30, 2020, the Company issued 100,000 shares of its common stock to two of its board members valued at $12,500 in exchange for services and expensed such services as consulting fees in the statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Consulting Fees</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended September 30, 2020 and 2019, the Company incurred consulting fees in the amount of $39,500 and $48,000, respectively to an officer, an officer of one of its affiliates and a promoter.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 9 &#8211; Subsequent Events</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s Form S-1 Registration Statement filed with the Securities and Exchange Commission became effective on October 16, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Principles of Consolidation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements include the accounts of Bio Lab Naturals, Inc. and its wholly owned subsidiary. All intercompany balances have been eliminated during consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates in the Preparation of Consolidated Financial Statements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates include the fair value of assets and liabilities, income taxes and the valuation allowances related to accounts receivable, deferred tax assets and contingencies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash and Cash Equivalents</u>&#9;</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 0 10.85pt; text-align: justify">The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Concentration of Credit Risk </u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company offers its services to a small number of clients. This risk of non-payment by these clients is considered minimal and the Company does not generally obtain collateral for sales. The Company continually monitors the credit standing of its clients.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts Receivable</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records accounts receivable at net realizable value. This value includes an appropriate allowance for uncollectible accounts to reflect any loss anticipated on the accounts receivable balances and is charged to other income (expense) in the statements of operations. Management calculates this allowance based on its history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and the Company&#8217;s relationships with, and the economic status of, its clients. At September 30, 2020 and December 31, 2019, there are no allowance for uncollectible accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Equipment</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Equipment is recorded at cost and consists of video equipment. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation of video equipment is over the estimated useful life of five years using the straight-line method for consolidated financial statement purposes. At September 30, 2020 and December 31, 2019 there were capitalized costs of $177,281 and $ $160,536, respectively. Depreciation expense for the three ended September 30, 2020 and 2019 was $8,783 and $0, respectively and for the nine months ended September 30, 2020 and 2019 was $25,681 and $0, respectively. See Note 4 &#8211; Fair Value Measurements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue recognition </u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows the provisions of Accounting Standards Update (&#8220;ASU&#8221;) No.&#160;2014&#160;-&#160;09,&#160;<i>Revenue from Contracts with Customers (Topic&#160;606), </i>using the full retrospective transition method. The Company&#8217;s adoption of ASU&#160;2014&#160;-&#160;09&#160;did not have a material impact on the amount and timing of revenue recognized in its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under ASU&#160;2014&#160;-&#160;09, the Company recognizes revenue when control of the promised services is transferred to clients, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company derives its revenues from the rendering of entertainment rental services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its contracts:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Identify the contract with a client;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Identify the performance obligations in the contract;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Determine the transaction price;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Allocate the transaction price to performance obligations in the contract; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Recognize revenue as the performance obligation is satisfied.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Impairment of Long-Lived Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with authoritative guidance on accounting for the impairment or disposal of long-lived assets, as set forth in Topic 360 of the ASC, the Company assesses the recoverability of the carrying value of its long-lived assets when events occur that indicate an impairment in value may exist. An impairment loss is indicated if the sum of the expected undiscounted future net cash flows is less than the carrying amount of the assets. If this occurs, an impairment loss is recognized for the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Other Comprehensive Loss</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has no material components of other comprehensive loss and accordingly, net loss is equal to comprehensive loss for the period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income Taxes</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company uses the liability method of accounting for income taxes under which deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the accounting bases and the tax bases of the Company&#8217;s assets and liabilities. The deferred tax assets and liabilities are computed using enacted tax rates in effect for the year in which the temporary differences are expected to reverse.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's deferred income taxes include certain future tax benefits. The Company records a valuation allowance against any portion of those deferred income tax assets when it believes, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred income tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has adopted ASC guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the consolidated financial statements and applies to all income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the consolidated financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. At September 30, 2020 and December 31, 2019, there were no uncertain tax positions that required accrual.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Goodwill</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with generally accepted accounting principles, goodwill cannot be amortized, however, it must be tested annually for impairment. This impairment test is calculated at the reporting unit level. The goodwill impairment test has two steps. The first identifies potential impairments by comparing the fair value of a reporting unit with its book value, including goodwill. If the fair value of the reporting unit exceeds the carrying amount, goodwill is not impaired and the second step is not necessary. If the carrying value exceeds the fair value, the second step calculates the possible impairment loss by comparing the implied fair value of goodwill with the carrying amount. If the implied goodwill is less than the carrying amount, a write-down is recorded. Management tests goodwill each year for impairment, or when facts or circumstances indicate impairment has occurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Net Loss per Share</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic net loss per common share of stock is calculated by dividing net loss available to common stockholders by the weighted-average number of common shares outstanding during each period. Diluted net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding, including the effect of other dilutive securities. The Company&#8217;s had no potentially dilutive securities issued as of and during the three and nine months ended September 30, 2020 and 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Equity Based Payments</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes compensation cost for equity-based awards based on estimated fair value of the award and records capitalized cost or compensation expense over the requisite service period. &#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Off-Balance Sheet Arrangements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As part of its ongoing business, the Company has not participated in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities (SPEs), which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. For the period through September 30,&#160;2020, the Company has not been involved in any unconsolidated SPE transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Subsequent Events</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates events and transactions after the balance sheet date but before the consolidated financial statements are issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the Company&#8217;s non-financial assets and liabilities that were measured at fair value on a non-recurring basis at December 31, 2019 by level within the fair value hierarchy:</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Description</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Total</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;&#160;&#160;&#160;&#160;&#160;Assets&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 1%">&#160;</td> <td style="width: 20%">&#160;Equipment&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">&#8212;&#160;&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">&#8212;&#160;&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">160,536</td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">160,536</td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;Goodwill&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>$</td> <td style="text-align: right">&#8212;&#160;&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>$</td> <td style="text-align: right">&#8212;&#160;&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>$</td> <td style="text-align: right">1,429,107</td> <td>&#160;</td> <td>&#160;</td> <td>$</td> <td style="text-align: right">1,429,107</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the allocation of the consideration given to the assets acquired and liabilities assumed, based on their fair values at December 31, 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><i>&#160;&#160;&#160;&#160;Consideration Given</i></td> <td>&#160;</td> <td colspan="3">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 71%; padding-bottom: 1pt">Shares of common stock</td> <td style="width: 10%; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; width: 1%">$</td> <td style="border-bottom: black 1pt solid; width: 17%; text-align: right">1,650,000</td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: center">Total purchase price</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,650,000</td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><i>&#160;&#160;&#160;&#160;&#160;Allocation of Consideration Given</i></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Cash</td> <td>&#160;</td> <td>$</td> <td style="text-align: right">69,527</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Accounts receivable, net</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">13,000</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Equipment</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">160,536</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt">Goodwill</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">1,429,107</td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center">Total assets</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">1,672,170</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt">Current liabilities</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">22,170</td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: center">Net assets acquired</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,650,000</td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> 12500 Net loss is less than $0.01 per share. EX-101.SCH 7 blab-20200930.xsd 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Organization and History link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Going Concern and Managements' Plan link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Significant Acquisition link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Equity Based Payments link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Significant Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Organization and History (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Going Concern and Managements' Plan (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Fair Value Measurements (Schedule of Non-Financial Assets and Liabilities Measured on Non-Recurring Basis) (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Significant Acquisition (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Significant Acquisition (Schedule of Allocation of Consideration Given to Assets Acquired and Liabilities Assumed) (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Debt (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Equity Based Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 blab-20200930_cal.xml EX-101.DEF 9 blab-20200930_def.xml EX-101.LAB 10 blab-20200930_lab.xml Equity Components [Axis] Class A Convertible Preferred $0.0001 Par Value [Member] Common Shares $0.0001 Par Value [Member] Additional Paid-in Capital [Member] Accumulated (Deficit) [Member] Class A Convertible [Member] Title of Individual [Axis] Affiliate officers [Member] Debt Instrument [Axis] Unsecured convertible promissory note [Member] Board members [Member] Officers and Affiliate [Member] Sale of Stock [Axis] Private Placement [Member] An affiliate of an officer of Company [Member] Business Acquisition [Axis] Prime Time Live, Inc [Member] Measurement Frequency [Axis] Nonrecurring [Member] Fair Value Hierarchy and NAV [Axis] Level 1 [Member] Level 2 [Member] Level 3 [Member] Plan Name [Axis] 2020 Stock Incentive Plan [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] Assets Current assets Cash Accounts receivable, net Prepaids Total current assets Equipment Equipment, net of accumulated depreciation, $25,681 Total Assets Liabilities and Stockholders' Equity Current liabilities Accounts payable Earnest money deposit Due to others Due to related party Note payable, related party Total current liabilities Total liabilities Commitments and Contingencies Stockholders' Equity Preferred shares, $0.0001 par value, 5,000,000 shares authorized; Class A Convertible, deemed par value $0.04 per share; 500,000 shares issued and outstanding at September 30, 2020 and December 31, 2019 Common shares, $0.0001 par value, 200,000,000 shares authorized; 10,753,504 and 8,477,505 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively Additional paid in capital Retained (deficit) Total stockholders' equity Total Liabilities and Stockholders' Equity Statement [Table] Statement [Line Items] Accumulated depreciation Preferred shares, par value Preferred shares, shares authorized Preferred shares, shares issued Preferred shares, shares outstanding Common shares, par value Common shares, shares authorized Common shares, shares issued Common shares, shares outstanding Income Statement [Abstract] Sales Cost of sales Cost of sales - other Depreciation Total cost of sales Gross profit Operating expenses Consulting fees - related party Consulting fees General and administrative expenses - other Professional fees Total operating expenses Loss from operations Other (expense) Interest expense Loss before income taxes Income taxes Net loss Net loss per common share - basic and diluted Weighted average number of common shares BALANCES BALANCES, Shares Issuance of shares for services Issuance of shares for services, Shares Issuance of shares for conversion of debt Issuance of shares for conversion of debt, Shares Sale of shares for cash at $0.125 per share Sale of shares for cash at $0.125 per share, Shares Net loss for the period BALANCES BALANCES, Shares Statement of Stockholders' Equity [Abstract] Sale of stock price per share Statement of Cash Flows [Abstract] OPERATING ACTIVITIES Net loss Adjustment to reconcile net loss to net cash flows used in operating activities Issuance of shares for services Changes in: Accounts receivable - net Deposits Accounts payable and accrued liabilities Net cash (used in) operating activities INVESTING ACTIVITIES Purchase of equipment FINANCING ACTIVITIES Funds from sale of common shares Funds from over subscription Funds from earnest money deposit Funds from loans, net of repayments - related party Net cash provided by financing activities Net increase in cash Cash at beginning of period Cash at end of period Supplemental Schedule of Cash Flow Information: Interest paid Income taxes paid Supplemental Schedule of Non-Cash Flow Information Issuance of shares for debt Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and History Accounting Policies [Abstract] Summary of Significant Accounting Policies Going Concern And Managements Plan Going Concern and Managements' Plan Fair Value Disclosures [Abstract] Fair Value Measurements Business Combinations [Abstract] Significant Acquisition Debt Disclosure [Abstract] Debt Stockholders' Equity Note [Abstract] Stockholders' Equity Share-based Payment Arrangement [Abstract] Equity Based Payments Related Party Transactions [Abstract] Related Party Transactions Subsequent Events [Abstract] Subsequent Events Principles of Consolidation Use of Estimates in the Preparation of Consolidated Financial Statements Cash and Cash Equivalents Concentration of Credit Risk Accounts Receivable Equipment Revenue recognition Impairment of Long-Lived Assets Other Comprehensive Loss Income Taxes Goodwill Net Loss per Share Equity Based Payments Off-Balance Sheet Arrangements Subsequent Events Schedule of Non-Financial Assets and Liabilities Measured at Fair Value on Non-Recurring Basis Schedule of Allocation of Consideration Given to Assets Acquired and Liabilities Assumed Capitalized costs Depreciation expense Net loss Accumulated deficit Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets Equipment Goodwill Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Common stock value Consideration Given Shares of common stock Total purchase price Allocation of Consideration Given Cash Accounts receivable, net Equipment Goodwill Total assets Current liabilities Net assets acquired Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Debt instrument face amount Interest rate Debt conversion shares issued, price per share Debt conversion shares issued Debt conversion shares issued, value Debt instrument face amount owed Accrued interest Voting rights Sale of shares for cash Sale of shares for cash, Shares Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Options term Common stock issued Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Affiliate of one of its officers [Member] Consulting fees, related party Repayments of Unsecured Debt Unsecured Debt Class A Convertible Preferred $0.0001 Par Value [Member] Earnest money deposit liability current as of balance sheet date. Class A Convertible [Member] Amount of consulting fees. Amount of consulting fees related party. The cash inflow from earnest money deposit. Affiliate officers [Member] Unsecured convertible promissory note [Member] Affiliate of one of its officers [Member] Affiliate of two of its officers [Member] Board members [Member] Officers and Affiliate [Member] 2014 Stock Incentive Plan [Member] An affiliate of an officer of Company [Member] Face (par) amount of debt instrument owed at time of reporting period end. Prime Time Live, Inc [Member] 2020 Stock Incentive Plan [Member] Assets, Current Assets [Default Label] Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Cost of Revenue Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Shares, Outstanding Other Operating Activities, Cash Flow Statement Increase (Decrease) in Accounts Receivable Increase (Decrease) in Deposit Assets Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Stockholders' Equity Note Disclosure [Text Block] Property, Plant and Equipment, Policy [Policy Text Block] Shareholders' Equity and Share-based Payments [Text Block] Subsequent Events, Policy [Policy Text Block] Property, Plant, and Equipment, Fair Value Disclosure Goodwill, Fair Value Disclosure Business Combination, Consideration Transferred Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Equipment Goodwill [Default Label] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net EX-101.PRE 11 blab-20200930_pre.xml XML 12 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information - shares
 9 Months Ended
Sep. 30, 2020
Oct. 30, 2020
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2020  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2020  
Current Fiscal Year End Date --12-31  
Entity File Number 333-239640  
Entity Registrant Name BIO LAB NATURALS, INC.  
Entity Central Index Key 0001803977  
Entity Tax Identification Number 84-2288662  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 7400 E. Crestline Circle  
Entity Address, Address Line Two Suite 130  
Entity Address, City or Town Greenwood Village  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80111  
City Area Code (720)  
Local Phone Number 273-0433  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   10,753,504
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current assets    
Cash $ 122,752 $ 69,527
Accounts receivable, net 13,000
Prepaids 12,500
Total current assets 135,252 82,527
Equipment    
Equipment, net of accumulated depreciation, $25,681 177,281 160,536
Total Assets 312,533 243,063
Current liabilities    
Accounts payable 16,456 18,900
Due to related party 3,270
Total current liabilities 16,456 22,170
Total liabilities 16,456 22,170
Commitments and Contingencies
Stockholders' Equity    
Preferred shares, $0.0001 par value, 5,000,000 shares authorized; Class A Convertible, deemed par value $0.04 per share; 500,000 shares issued and outstanding at September 30, 2020 and December 31, 2019 50 50
Common shares, $0.0001 par value, 200,000,000 shares authorized; 10,753,504 and 8,477,505 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively 1,075 848
Additional paid in capital 35,672,338 35,388,065
Retained (deficit) (35,377,386) (35,168,070)
Total stockholders' equity 296,077 220,893
Total Liabilities and Stockholders' Equity $ 312,533 $ 243,063
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Accumulated depreciation $ 25,681 $ 25,681
Preferred shares, par value $ 0.0001 $ 0.0001
Preferred shares, shares authorized 5,000,000 5,000,000
Common shares, par value $ 0.0001 $ 0.0001
Common shares, shares authorized 200,000,000 200,000,000
Common shares, shares issued 10,753,504 8,477,505
Common shares, shares outstanding 10,753,504 8,477,505
Class A Convertible [Member]    
Preferred shares, par value $ 0.04 $ 0.04
Preferred shares, shares issued 500,000 500,000
Preferred shares, shares outstanding 500,000 500,000
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Sales $ 21,000 $ 21,000
Cost of sales        
Cost of sales - other 25,580 36,639
Depreciation 8,783 25,681
Total cost of sales 34,363 62,320
Gross profit (13,363) (41,320)
Operating expenses        
Consulting fees - related party 48,000 39,500 48,000
Consulting fees 3,360 13,860
General and administrative expenses - other 12,606 25,000 28,984 25,000
Professional fees 28,385 85,401
Total operating expenses 44,351 73,000 167,745 73,000
Loss from operations (57,714) (73,000) (209,065) (73,000)
Other (expense)        
Interest expense (240) (251) (240)
Loss before income taxes (57,714) (73,240) (209,316) (73,240)
Income taxes
Net loss $ (57,714) $ (73,240) $ (209,316) $ (73,240)
Net loss per common share - basic and diluted [1] $ (0.02)
Weighted average number of common shares 10,753,504 9,308,566 9,388,570 9,308,566
[1] Net loss is less than $0.01 per share.
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - 9 months ended Sep. 30, 2020 - USD ($)
Class A Convertible Preferred $0.0001 Par Value [Member]
Common Shares $0.0001 Par Value [Member]
Additional Paid-in Capital [Member]
Accumulated (Deficit) [Member]
Total
BALANCES at Dec. 31, 2019 $ 50 $ 848 $ 35,388,065 $ (35,168,070) $ 220,893
BALANCES, Shares at Dec. 31, 2019 500,000 8,477,505      
Issuance of shares for services $ 10 12,490 12,500
Issuance of shares for services, Shares 100,000      
Issuance of shares for conversion of debt $ 8 9,992 10,000
Issuance of shares for conversion of debt, Shares 80,000      
Sale of shares for cash at $0.125 per share $ 209 261,791 262,000
Sale of shares for cash at $0.125 per share, Shares 2,095,999      
Net loss for the period (209,316) (209,316)
BALANCES at Sep. 30, 2020 $ 50 $ 1,075 $ 35,672,338 $ (35,377,386) $ 296,077
BALANCES, Shares at Sep. 30, 2020 500,000 10,753,504      
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical)
Sep. 30, 2020
$ / shares
Statement of Stockholders' Equity [Abstract]  
Sale of stock price per share $ 0.125
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
OPERATING ACTIVITIES    
Net loss $ (209,316) $ (73,240)
Adjustment to reconcile net loss to net cash flows used in operating activities    
Depreciation 25,681
Issuance of shares for services 12,500
Changes in:    
Accounts receivable - net 13,000
Deposits (12,500)
Accounts payable and accrued liabilities (12,444) 48,240
Net cash (used in) operating activities (183,079) (25,000)
INVESTING ACTIVITIES    
Purchase of equipment (32,426)
FINANCING ACTIVITIES    
Funds from sale of common shares 262,000
Funds from loans, net of repayments - related party 6,730 25,000
Net cash provided by financing activities 268,730 25,000
Net increase in cash 53,225
Cash at beginning of period 69,527
Cash at end of period 122,752
Supplemental Schedule of Cash Flow Information:    
Interest paid 251
Income taxes paid
Supplemental Schedule of Non-Cash Flow Information    
Issuance of shares for debt $ 10,000
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Organization and History
 9 Months Ended
Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and History

Note 1 – Organization and History

Vyta Corp (the “Company”) was incorporated in Nevada in June 1996. On August 20, 2010, it changed its state of incorporation to Delaware and on November 5, 2010 it changed its name to Bio Lab Naturals, Inc. On August 20, 2010, the Company executed a redomicile merger with its wholly owned subsidiary Vyta Corp (Delaware), as result of the merger the Company’s corporate domicile moved from Nevada to Delaware.

 

Prior to 2011, the Company was involved in various business activities and since then the Company has been seeking a business opportunity.

 

Effective December 31, 2019, the Company entered into a Reorganization Agreement with Prime Time Live, Inc., a Colorado corporation (“PTL”), whereby PTL merged with a newly formed wholly owned subsidiary of the Company, and the subsidiary being the survivor in exchange for the Company issuing one share of its common stock for each share of PTL’s 5,500,000 issued and outstanding shares of common stock. See Note 5 – Significant Acquisition.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of Bio Lab Naturals, Inc. and its wholly owned subsidiary. All intercompany balances have been eliminated during consolidation.

 

Use of Estimates in the Preparation of Consolidated Financial Statements

 

The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates include the fair value of assets and liabilities, income taxes and the valuation allowances related to accounts receivable, deferred tax assets and contingencies.

 

Cash and Cash Equivalents

 

The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”).

Concentration of Credit Risk

 

The Company offers its services to a small number of clients. This risk of non-payment by these clients is considered minimal and the Company does not generally obtain collateral for sales. The Company continually monitors the credit standing of its clients.

 

Accounts Receivable

 

The Company records accounts receivable at net realizable value. This value includes an appropriate allowance for uncollectible accounts to reflect any loss anticipated on the accounts receivable balances and is charged to other income (expense) in the statements of operations. Management calculates this allowance based on its history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and the Company’s relationships with, and the economic status of, its clients. At September 30, 2020 and December 31, 2019, there are no allowance for uncollectible accounts.

 

Equipment

 

Equipment is recorded at cost and consists of video equipment. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation of video equipment is over the estimated useful life of five years using the straight-line method for consolidated financial statement purposes. At September 30, 2020 and December 31, 2019 there were capitalized costs of $177,281 and $ $160,536, respectively. Depreciation expense for the three ended September 30, 2020 and 2019 was $8,783 and $0, respectively and for the nine months ended September 30, 2020 and 2019 was $25,681 and $0, respectively. See Note 4 – Fair Value Measurements.

 

Revenue recognition

 

The Company follows the provisions of Accounting Standards Update (“ASU”) No. 2014 - 09, Revenue from Contracts with Customers (Topic 606), using the full retrospective transition method. The Company’s adoption of ASU 2014 - 09 did not have a material impact on the amount and timing of revenue recognized in its consolidated financial statements.

 

Under ASU 2014 - 09, the Company recognizes revenue when control of the promised services is transferred to clients, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.

 

The Company derives its revenues from the rendering of entertainment rental services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its contracts:

 

Identify the contract with a client;

Identify the performance obligations in the contract;

Determine the transaction price;

Allocate the transaction price to performance obligations in the contract; and

Recognize revenue as the performance obligation is satisfied.

 

Impairment of Long-Lived Assets

 

In accordance with authoritative guidance on accounting for the impairment or disposal of long-lived assets, as set forth in Topic 360 of the ASC, the Company assesses the recoverability of the carrying value of its long-lived assets when events occur that indicate an impairment in value may exist. An impairment loss is indicated if the sum of the expected undiscounted future net cash flows is less than the carrying amount of the assets. If this occurs, an impairment loss is recognized for the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets.

 

Other Comprehensive Loss

 

The Company has no material components of other comprehensive loss and accordingly, net loss is equal to comprehensive loss for the period.

 

Income Taxes

 

The Company uses the liability method of accounting for income taxes under which deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the accounting bases and the tax bases of the Company’s assets and liabilities. The deferred tax assets and liabilities are computed using enacted tax rates in effect for the year in which the temporary differences are expected to reverse.

 

The Company's deferred income taxes include certain future tax benefits. The Company records a valuation allowance against any portion of those deferred income tax assets when it believes, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred income tax asset will not be realized.

 

The Company has adopted ASC guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the consolidated financial statements and applies to all income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the consolidated financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. At September 30, 2020 and December 31, 2019, there were no uncertain tax positions that required accrual.

 

Goodwill

 

In accordance with generally accepted accounting principles, goodwill cannot be amortized, however, it must be tested annually for impairment. This impairment test is calculated at the reporting unit level. The goodwill impairment test has two steps. The first identifies potential impairments by comparing the fair value of a reporting unit with its book value, including goodwill. If the fair value of the reporting unit exceeds the carrying amount, goodwill is not impaired and the second step is not necessary. If the carrying value exceeds the fair value, the second step calculates the possible impairment loss by comparing the implied fair value of goodwill with the carrying amount. If the implied goodwill is less than the carrying amount, a write-down is recorded. Management tests goodwill each year for impairment, or when facts or circumstances indicate impairment has occurred.

 

Net Loss per Share

 

Basic net loss per common share of stock is calculated by dividing net loss available to common stockholders by the weighted-average number of common shares outstanding during each period. Diluted net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding, including the effect of other dilutive securities. The Company’s had no potentially dilutive securities issued as of and during the three and nine months ended September 30, 2020 and 2019.

 

Equity Based Payments

 

The Company recognizes compensation cost for equity-based awards based on estimated fair value of the award and records capitalized cost or compensation expense over the requisite service period.  

 

Off-Balance Sheet Arrangements

 

As part of its ongoing business, the Company has not participated in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities (SPEs), which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. For the period through September 30, 2020, the Company has not been involved in any unconsolidated SPE transactions.

 

Subsequent Events

 

The Company evaluates events and transactions after the balance sheet date but before the consolidated financial statements are issued.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Going Concern and Managements' Plan
 9 Months Ended
Sep. 30, 2020
Going Concern And Managements Plan  
Going Concern and Managements' Plan

Note 3 – Going Concern and Managements’ Plan

 

The Company’s consolidated financial statements for the three and nine months ended September 30, 2020 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Company reported a net loss for the three and nine months ended September 30, 2020 of $57,714 and $209,316, respectively and an accumulated deficit of $35,377,386 at September 30, 2020.

 

The Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern within one year after the date of the issuance of these financial statements. The future success of the Company is dependent on its ability to attract additional capital and ultimately, upon its ability to develop future profitable operations. There can be no assurance that the Company will be successful in obtaining such financing, or that it will attain positive cash flow from operations. However, management believes that actions presently being taken to raise additional capital as more fully disclosed in these financial statements provides the opportunity for the Company to continue as a going concern.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurements
 9 Months Ended
Sep. 30, 2020
Fair Value Disclosures [Abstract]  
Fair Value Measurements

Note 4 – Fair Value Measurements

 

The Company applies the authoritative guidance applicable to all financial assets and liabilities required to be measured and reported on a fair value basis, as well as to non-financial assets and liabilities measured at fair value on a non-recurring basis, including impairments of long-lived assets. The fair value of an asset or liability is the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. Observable inputs are inputs that market participants would use in valuing the asset or liability based on market data obtained from sources independent of the Company. Unobservable input are inputs that reflect the Company’s assumptions of what market participants would use in valuing the asset or liability based on the information available in the circumstances.

 

Financial and non-financial assets and liabilities are classified within the valuation hierarchy based upon the lowest level of input that is significant to the fair value measurement. The Company’s policy is to recognize transfers in and out of the fair value hierarchy as of the end of the reporting period in which the event or change in circumstances caused the transfer. The Company has consistently applied the valuation techniques discussed below in all periods presented. The hierarchy is organized into three levels based on the reliability of the inputs as follows:

 

Level 1: Quoted prices in active markets for identical assets or liabilities; or

Level 2: Quoted prices in active markets for similar assets and liabilities and inputs, quoted prices for identical or similar assets or liabilities in markets that are not active and model-derived valuations whose inputs or significant value drivers are observable; or

Level 3: Unobservable pricing inputs in which there is little or no market data, which requires the reporting entity to develop its own assumptions.

 

The following table presents the Company’s non-financial assets and liabilities that were measured at fair value on a non-recurring basis at December 31, 2019 by level within the fair value hierarchy:

 

Description   Level 1   Level 2   Level 3   Total
        Assets                                   
   Equipment      $ —       $ —       $ 160,536     $ 160,536  
   Goodwill      $ —       $ —       $ 1,429,107     $ 1,429,107  

 

Effective December 31 2019, the Company’s equipment was tested under ASC 360 as to its recoverability to determine if impairment is required under the accounting guidance. The Company used Level 3 inputs to measure the fair value of the assets. As such, there was no impairment.

 

Effective December 31, 2019, the Company acquired Prime Time Live Inc. and as a result realized goodwill in the amount of $1,429,107. Thus, due to the significance of this event, goodwill was tested under ASC 360 as to its recoverability. Therefore, goodwill is recorded at fair value if impairment is required under the accounting guidance. The Company used Level 3 inputs to measure the fair value of the asset and management determined that there were no future undiscounted cash flows associated with goodwill. As such, the Company’s goodwill was fully impaired at December 31, 2019 in the amount of $1,429,107.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Significant Acquisition
 9 Months Ended
Sep. 30, 2020
Business Combinations [Abstract]  
Significant Acquisition

Note 5 – Significant Acquisition

 

Effective December 31, 2019, the Company entered into a Reorganization Agreement with Prime Time Live, Inc., a Colorado corporation whereby PTL merged with a newly formed wholly owned subsidiary of the Company, and the subsidiary being the survivor in exchange for the Company issuing one share of its common stock for each share of PTL’s 5,500,000 issued and outstanding shares of common stock valued at $0.30 per share, based upon the stock price on the OTC markets at December 31, 2019, or a total value of $1,650,000.

 

The following table presents the allocation of the consideration given to the assets acquired and liabilities assumed, based on their fair values at December 31, 2019:

 

    Consideration Given    
Shares of common stock   $ 1,650,000  
         
Total purchase price   $ 1,650,000  
         
     Allocation of Consideration Given        
Cash   $ 69,527  
Accounts receivable, net     13,000  
Equipment     160,536  
Goodwill     1,429,107  
         
Total assets     1,672,170  
         
Current liabilities     22,170  
         
Net assets acquired   $ 1,650,000  
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Debt
 9 Months Ended
Sep. 30, 2020
Debt Disclosure [Abstract]  
Debt

Note 6 – Debt

 

Convertible Promissory Note

 

An affiliate of an officer of the Company, loaned the Company $14,200 in exchange for an unsecured convertible promissory note that included interest at the rate of six percent (6%) per annum on the unpaid principal balance with any accrued and unpaid interest due on or before December 31, 2020 (the “Note”). The Note allowed for the note holder to convert, at their discretion, any accrued and unpaid interest and principal balance due on the Note in whole or in part into shares of the Company’s common stock at a conversion price of $0.125 per share. On June 12, 2020, the note holder converted $10,000 of the Note into 80,000 shares of the Company’s common stock and on July 1, 2020 the Company repaid $4,200 in principal on the Note plus $251 in interest. At September 30, 2020, the Note was paid in full. See Note 9 - Related Party Transactions.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity
 9 Months Ended
Sep. 30, 2020
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

Note 7 – Stockholders’ Equity

 

Preferred Shares

 

Class A Convertible

 

At September 30, 2020, there are a total of 500,000 shares of Class A Convertible shares of preferred stock (“Class A”) issued and outstanding. The Class A shares provide that when voting as a single class, the shares shall have the votes and the voting power at all times to be at least 60% of the voting power of the Company. Further, the holders of the Class A shares at their discretion and subject to a change of control and to the qualification by application to either NASQAD or NYSE Emerging Markets, can convert their one share of Class A into two shares of the Company’s common stock, subject to adjustment. In addition, the holder of the shares of Class A is entitled to a liquidation preference of the Company senior to all other securities of the Company.

 

Common Shares

 

The Company’s capital stock at September 30, 2020 consists of 200,000,000 authorized shares of $0.0001 par value common stock. At September 30, 2020, there are a total of 10,753,504 shares of common stock issued and outstanding.

 

During the nine months ended September 30, 2020, the Company sold 2,095,999 of its common stock as part of a private placement for $262,000 in cash or $0.125 per share, issued 100,000 shares of its common for services rendered in the amount of $12,500 and issued 80,000 shares of its common stock to convert debt in the amount of $10,000. See Note 9 – Related Party Transactions.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Based Payments
 9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Equity Based Payments

Note 8 – Equity Based Payments

 

The Company accounts for equity-based payment accruals under authoritative guidance as set forth in the Topics of the ASC. The guidance requires all equity-based payments to employees and non-employees, including grants of employee and non-employee stock options and warrants, to be recognized in the consolidated financial statements based at their fair values.

 

2014 Stock Incentive Plan

 

Effective January 15, 2020, the Company’s adopted its 2020 Stock Option and Award Plan (the “2020 Stock Incentive Plan”). Under the 2020 Stock Incentive Plan, the Board of Directors may grant options or purchase rights to purchase common stock to officers, employees, and other persons who provide services to the Company or any related company. The participants to whom awards are granted, the type of awards granted, the number of shares covered for each award, and the purchase price, conditions and other terms of each award are determined by the Board of Directors, except that the term of the options shall not exceed 10 years. A total of 2 million shares of the Company’s common stock are subject to the 2020 Stock Incentive Plan. The shares issued for the 2020 Stock Incentive Plan may be either treasury or authorized and unissued shares. During the three and nine months ended September 30, 2020, the Company granted no options under the 2020 Stock Incentive Plan.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions
 9 Months Ended
Sep. 30, 2020
Related Party Transactions [Abstract]  
Related Party Transactions

Note 9 – Related Party Transactions

 

Due to Related Parties

 

During the three months ended September 30, 2020, the Company repaid an affiliate of one of its officers $4,200 in principal plus $251 in interest toward an unsecured convertible promissory note.

 

During the three months ended September 30, 2020, the Company repaid an affiliate of one of its officers $3,270 on an unsecured loan and at September 30, 2020 owes $0.

 

During the nine months ended September 30, 2020, the Company repaid an affiliate of one of its officers $10,000 toward an unsecured convertible promissory note by issuing 80,000 shares of its common stock value at $0.125 per share.

 

Equity for Services

 

During the nine months ended September 30, 2020, the Company issued 100,000 shares of its common stock to two of its board members valued at $12,500 in exchange for services and expensed such services as consulting fees in the statement of operations.

 

Consulting Fees

 

During the nine months ended September 30, 2020 and 2019, the Company incurred consulting fees in the amount of $39,500 and $48,000, respectively to an officer, an officer of one of its affiliates and a promoter.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events
 9 Months Ended
Sep. 30, 2020
Subsequent Events [Abstract]  
Subsequent Events

Note 9 – Subsequent Events

 

The Company’s Form S-1 Registration Statement filed with the Securities and Exchange Commission became effective on October 16, 2020.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Principles of Consolidation

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of Bio Lab Naturals, Inc. and its wholly owned subsidiary. All intercompany balances have been eliminated during consolidation.
Use of Estimates in the Preparation of Consolidated Financial Statements

Use of Estimates in the Preparation of Consolidated Financial Statements

 

The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates include the fair value of assets and liabilities, income taxes and the valuation allowances related to accounts receivable, deferred tax assets and contingencies.
Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”).
Concentration of Credit Risk

Concentration of Credit Risk

 

The Company offers its services to a small number of clients. This risk of non-payment by these clients is considered minimal and the Company does not generally obtain collateral for sales. The Company continually monitors the credit standing of its clients.
Accounts Receivable

Accounts Receivable

 

The Company records accounts receivable at net realizable value. This value includes an appropriate allowance for uncollectible accounts to reflect any loss anticipated on the accounts receivable balances and is charged to other income (expense) in the statements of operations. Management calculates this allowance based on its history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and the Company’s relationships with, and the economic status of, its clients. At September 30, 2020 and December 31, 2019, there are no allowance for uncollectible accounts.
Equipment

Equipment

 

Equipment is recorded at cost and consists of video equipment. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation of video equipment is over the estimated useful life of five years using the straight-line method for consolidated financial statement purposes. At September 30, 2020 and December 31, 2019 there were capitalized costs of $177,281 and $ $160,536, respectively. Depreciation expense for the three ended September 30, 2020 and 2019 was $8,783 and $0, respectively and for the nine months ended September 30, 2020 and 2019 was $25,681 and $0, respectively. See Note 4 – Fair Value Measurements.
Revenue recognition

Revenue recognition

 

The Company follows the provisions of Accounting Standards Update (“ASU”) No. 2014 - 09, Revenue from Contracts with Customers (Topic 606), using the full retrospective transition method. The Company’s adoption of ASU 2014 - 09 did not have a material impact on the amount and timing of revenue recognized in its consolidated financial statements.

 

Under ASU 2014 - 09, the Company recognizes revenue when control of the promised services is transferred to clients, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.

 

The Company derives its revenues from the rendering of entertainment rental services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its contracts:

 

Identify the contract with a client;

Identify the performance obligations in the contract;

Determine the transaction price;

Allocate the transaction price to performance obligations in the contract; and

Recognize revenue as the performance obligation is satisfied.
Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

In accordance with authoritative guidance on accounting for the impairment or disposal of long-lived assets, as set forth in Topic 360 of the ASC, the Company assesses the recoverability of the carrying value of its long-lived assets when events occur that indicate an impairment in value may exist. An impairment loss is indicated if the sum of the expected undiscounted future net cash flows is less than the carrying amount of the assets. If this occurs, an impairment loss is recognized for the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets.
Other Comprehensive Loss

Other Comprehensive Loss

 

The Company has no material components of other comprehensive loss and accordingly, net loss is equal to comprehensive loss for the period.
Income Taxes

Income Taxes

 

The Company uses the liability method of accounting for income taxes under which deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the accounting bases and the tax bases of the Company’s assets and liabilities. The deferred tax assets and liabilities are computed using enacted tax rates in effect for the year in which the temporary differences are expected to reverse.

 

The Company's deferred income taxes include certain future tax benefits. The Company records a valuation allowance against any portion of those deferred income tax assets when it believes, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred income tax asset will not be realized.

 

The Company has adopted ASC guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the consolidated financial statements and applies to all income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the consolidated financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. At September 30, 2020 and December 31, 2019, there were no uncertain tax positions that required accrual.
Goodwill

Goodwill

 

In accordance with generally accepted accounting principles, goodwill cannot be amortized, however, it must be tested annually for impairment. This impairment test is calculated at the reporting unit level. The goodwill impairment test has two steps. The first identifies potential impairments by comparing the fair value of a reporting unit with its book value, including goodwill. If the fair value of the reporting unit exceeds the carrying amount, goodwill is not impaired and the second step is not necessary. If the carrying value exceeds the fair value, the second step calculates the possible impairment loss by comparing the implied fair value of goodwill with the carrying amount. If the implied goodwill is less than the carrying amount, a write-down is recorded. Management tests goodwill each year for impairment, or when facts or circumstances indicate impairment has occurred.
Net Loss per Share

Net Loss per Share

 

Basic net loss per common share of stock is calculated by dividing net loss available to common stockholders by the weighted-average number of common shares outstanding during each period. Diluted net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding, including the effect of other dilutive securities. The Company’s had no potentially dilutive securities issued as of and during the three and nine months ended September 30, 2020 and 2019.
Equity Based Payments

Equity Based Payments

 

The Company recognizes compensation cost for equity-based awards based on estimated fair value of the award and records capitalized cost or compensation expense over the requisite service period.  
Off-Balance Sheet Arrangements

Off-Balance Sheet Arrangements

 

As part of its ongoing business, the Company has not participated in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities (SPEs), which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. For the period through September 30, 2020, the Company has not been involved in any unconsolidated SPE transactions.
Subsequent Events

Subsequent Events

 

The Company evaluates events and transactions after the balance sheet date but before the consolidated financial statements are issued.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2020
Fair Value Disclosures [Abstract]  
Schedule of Non-Financial Assets and Liabilities Measured at Fair Value on Non-Recurring Basis

The following table presents the Company’s non-financial assets and liabilities that were measured at fair value on a non-recurring basis at December 31, 2019 by level within the fair value hierarchy:

 

Description   Level 1   Level 2   Level 3   Total
        Assets                                   
   Equipment      $ —       $ —       $ 160,536     $ 160,536  
   Goodwill      $ —       $ —       $ 1,429,107     $ 1,429,107  
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Significant Acquisition (Tables)
 9 Months Ended
Sep. 30, 2020
Business Combinations [Abstract]  
Schedule of Allocation of Consideration Given to Assets Acquired and Liabilities Assumed

The following table presents the allocation of the consideration given to the assets acquired and liabilities assumed, based on their fair values at December 31, 2019:

 

    Consideration Given    
Shares of common stock   $ 1,650,000  
         
Total purchase price   $ 1,650,000  
         
     Allocation of Consideration Given        
Cash   $ 69,527  
Accounts receivable, net     13,000  
Equipment     160,536  
Goodwill     1,429,107  
         
Total assets     1,672,170  
         
Current liabilities     22,170  
         
Net assets acquired   $ 1,650,000  
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Organization and History (Details) - shares
Sep. 30, 2020
Dec. 31, 2019
Common shares, shares issued 10,753,504 8,477,505
Common shares, shares outstanding 10,753,504 8,477,505
Prime Time Live, Inc [Member]    
Common shares, shares issued   5,500,000
Common shares, shares outstanding   5,500,000
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Accounting Policies [Abstract]          
Capitalized costs $ 177,281   $ 177,281   $ 160,536
Depreciation expense $ 8,783 $ 25,681  
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Going Concern and Managements' Plan (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Going Concern And Managements Plan          
Net loss $ 57,714 $ 73,240 $ 209,316 $ 73,240  
Accumulated deficit $ 35,377,386   $ 35,377,386   $ 35,168,070
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurements (Schedule of Non-Financial Assets and Liabilities Measured on Non-Recurring Basis) (Details) - Nonrecurring [Member]
Dec. 31, 2019
USD ($)
Assets  
Equipment $ 160,536
Goodwill 1,429,107
Level 1 [Member]  
Assets  
Equipment
Goodwill
Level 2 [Member]  
Assets  
Equipment
Goodwill
Level 3 [Member]  
Assets  
Equipment 160,536
Goodwill $ 1,429,107
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Significant Acquisition (Narrative) (Details) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Business Acquisition [Line Items]    
Common shares, par value $ 0.0001 $ 0.0001
Common shares, shares issued 10,753,504 8,477,505
Common shares, shares outstanding 10,753,504 8,477,505
Common stock value $ 1,075 $ 848
Prime Time Live, Inc [Member]    
Business Acquisition [Line Items]    
Common shares, par value   $ 0.30
Common shares, shares issued   5,500,000
Common shares, shares outstanding   5,500,000
Common stock value   $ 1,650,000
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Significant Acquisition (Schedule of Allocation of Consideration Given to Assets Acquired and Liabilities Assumed) (Details) - Prime Time Live, Inc [Member]
 1 Months Ended
Dec. 31, 2019
USD ($)
Consideration Given  
Shares of common stock $ 1,650,000
Total purchase price 1,650,000
Allocation of Consideration Given  
Cash 69,527
Accounts receivable, net 13,000
Equipment 160,536
Goodwill 1,429,107
Total assets 1,672,170
Current liabilities 22,170
Net assets acquired $ 1,650,000
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Debt (Details) - An affiliate of an officer of Company [Member] - Unsecured convertible promissory note [Member] - USD ($)
Jun. 12, 2020
Sep. 30, 2020
Jul. 02, 2020
Debt Instrument [Line Items]      
Debt instrument face amount   $ 14,200  
Interest rate   6.00%  
Debt conversion shares issued, price per share   $ 0.125  
Debt conversion shares issued 80,000    
Debt conversion shares issued, value $ 10,000    
Debt instrument face amount owed     $ 4,200
Accrued interest     $ 251
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Details) - USD ($)
 9 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Common shares, par value $ 0.0001 $ 0.0001
Common shares, shares authorized 200,000,000 200,000,000
Common shares, shares issued 10,753,504 8,477,505
Common shares, shares outstanding 10,753,504 8,477,505
Sale of shares for cash $ 262,000  
Sale of stock price per share $ 0.125  
Issuance of shares for services $ 12,500  
Private Placement [Member]    
Sale of shares for cash $ 262,000  
Sale of shares for cash, Shares 2,095,999  
Sale of stock price per share $ 0.125  
Issuance of shares for services $ 12,500  
Issuance of shares for services, Shares 100,000  
Debt conversion shares issued 80,000  
Debt conversion shares issued, value $ 10,000  
Class A Convertible [Member]    
Preferred shares, shares issued 500,000 500,000
Preferred shares, shares outstanding 500,000 500,000
Voting rights The Class A shares provide that when voting as a single class, the shares shall have the votes and the voting power at all times to be at least 60% of the voting power of the Company.  
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Based Payments (Details) - 2020 Stock Incentive Plan [Member]
 9 Months Ended
Sep. 30, 2020
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Options term P10Y
Common stock issued 2,000,000
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Related Party Transaction [Line Items]        
Issuance of shares for services     $ 12,500  
Consulting fees, related party $ 48,000 39,500 $ 48,000
Interest paid     251
Affiliate officers [Member]        
Related Party Transaction [Line Items]        
Repayments of Unsecured Debt 3,270      
Unsecured Debt $ 0   $ 0  
Affiliate officers [Member] | Unsecured convertible promissory note [Member]        
Related Party Transaction [Line Items]        
Debt conversion shares issued, price per share $ 0.125   $ 0.125  
Repayments of Unsecured Debt $ 4,200   $ 10,000  
Interest paid $ 251      
Debt conversion shares issued 80,000      
Board members [Member]        
Related Party Transaction [Line Items]        
Issuance of shares for services $ 12,500      
Issuance of shares for services, Shares 100,000      
Officers and Affiliate [Member]        
Related Party Transaction [Line Items]        
Consulting fees, related party     $ 39,500 $ 48,000
EXCEL 42 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 44 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 45 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 44 213 1 true 17 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://biolabnaturals.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://biolabnaturals.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://biolabnaturals.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://biolabnaturals.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) Sheet http://biolabnaturals.com/role/ConsolidatedStatementOfChangesInStockholdersEquity CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://biolabnaturals.com/role/ConsolidatedStatementOfChangesInStockholdersEquityParenthetical CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) Statements 6 false false R7.htm 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://biolabnaturals.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 7 false false R8.htm 00000008 - Disclosure - Organization and History Sheet http://biolabnaturals.com/role/OrganizationAndHistory Organization and History Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://biolabnaturals.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Going Concern and Managements' Plan Sheet http://biolabnaturals.com/role/GoingConcernAndManagementsPlan Going Concern and Managements' Plan Notes 10 false false R11.htm 00000011 - Disclosure - Fair Value Measurements Sheet http://biolabnaturals.com/role/FairValueMeasurements Fair Value Measurements Notes 11 false false R12.htm 00000012 - Disclosure - Significant Acquisition Sheet http://biolabnaturals.com/role/SignificantAcquisition Significant Acquisition Notes 12 false false R13.htm 00000013 - Disclosure - Debt Sheet http://biolabnaturals.com/role/Debt Debt Notes 13 false false R14.htm 00000014 - Disclosure - Stockholders' Equity Sheet http://biolabnaturals.com/role/StockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 00000015 - Disclosure - Equity Based Payments Sheet http://biolabnaturals.com/role/EquityBasedPayments Equity Based Payments Notes 15 false false R16.htm 00000016 - Disclosure - Related Party Transactions Sheet http://biolabnaturals.com/role/RelatedPartyTransactions Related Party Transactions Notes 16 false false R17.htm 00000017 - Disclosure - Subsequent Events Sheet http://biolabnaturals.com/role/SubsequentEvents Subsequent Events Notes 17 false false R18.htm 00000018 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://biolabnaturals.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://biolabnaturals.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 00000019 - Disclosure - Fair Value Measurements (Tables) Sheet http://biolabnaturals.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://biolabnaturals.com/role/FairValueMeasurements 19 false false R20.htm 00000020 - Disclosure - Significant Acquisition (Tables) Sheet http://biolabnaturals.com/role/SignificantAcquisitionTables Significant Acquisition (Tables) Tables http://biolabnaturals.com/role/SignificantAcquisition 20 false false R21.htm 00000021 - Disclosure - Organization and History (Details) Sheet http://biolabnaturals.com/role/OrganizationAndHistoryDetails Organization and History (Details) Details http://biolabnaturals.com/role/OrganizationAndHistory 21 false false R22.htm 00000022 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://biolabnaturals.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://biolabnaturals.com/role/SummaryOfSignificantAccountingPoliciesPolicies 22 false false R23.htm 00000023 - Disclosure - Going Concern and Managements' Plan (Details) Sheet http://biolabnaturals.com/role/GoingConcernAndManagementsPlanDetails Going Concern and Managements' Plan (Details) Details http://biolabnaturals.com/role/GoingConcernAndManagementsPlan 23 false false R24.htm 00000024 - Disclosure - Fair Value Measurements (Schedule of Non-Financial Assets and Liabilities Measured on Non-Recurring Basis) (Details) Sheet http://biolabnaturals.com/role/FairValueMeasurementsScheduleOfNon-financialAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails Fair Value Measurements (Schedule of Non-Financial Assets and Liabilities Measured on Non-Recurring Basis) (Details) Details http://biolabnaturals.com/role/FairValueMeasurementsTables 24 false false R25.htm 00000025 - Disclosure - Significant Acquisition (Narrative) (Details) Sheet http://biolabnaturals.com/role/SignificantAcquisitionNarrativeDetails Significant Acquisition (Narrative) (Details) Details http://biolabnaturals.com/role/SignificantAcquisitionTables 25 false false R26.htm 00000026 - Disclosure - Significant Acquisition (Schedule of Allocation of Consideration Given to Assets Acquired and Liabilities Assumed) (Details) Sheet http://biolabnaturals.com/role/SignificantAcquisitionScheduleOfAllocationOfConsiderationGivenToAssetsAcquiredAndLiabilitiesAssumedDetails Significant Acquisition (Schedule of Allocation of Consideration Given to Assets Acquired and Liabilities Assumed) (Details) Details http://biolabnaturals.com/role/SignificantAcquisitionTables 26 false false R27.htm 00000027 - Disclosure - Debt (Details) Sheet http://biolabnaturals.com/role/DebtDetails Debt (Details) Details http://biolabnaturals.com/role/Debt 27 false false R28.htm 00000028 - Disclosure - Stockholders' Equity (Details) Sheet http://biolabnaturals.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://biolabnaturals.com/role/StockholdersEquity 28 false false R29.htm 00000029 - Disclosure - Equity Based Payments (Details) Sheet http://biolabnaturals.com/role/EquityBasedPaymentsDetails Equity Based Payments (Details) Details http://biolabnaturals.com/role/EquityBasedPayments 29 false false R30.htm 00000030 - Disclosure - Related Party Transactions (Details) Sheet http://biolabnaturals.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://biolabnaturals.com/role/RelatedPartyTransactions 30 false false All Reports Book All Reports blab-20200930.xml blab-20200930.xsd blab-20200930_cal.xml blab-20200930_def.xml blab-20200930_lab.xml blab-20200930_pre.xml http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true ZIP 47 0001065949-20-000144-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001065949-20-000144-xbrl.zip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

4Q-K8P\6],"("8'3+J(&I#*F \],;4I:F#RU]/ M;T=,_$,4\[/?$53Q/D^TK\(3ZWE+T4L)I0?2&:&37/CW9;J@$V*@I7J6YE$> M;\'O&A,"(%V'C#I(V) *=+]KISY4\]GYY>3R&*+?)7F+,4Y8I*YV8ID>2>GN MG=2\&@<[SP&=W;(QB/!L-@(C1%>FDNZ6>=+$9ZV:;5/.X3@":[#DV\+ZVZ9= M7LO ,+@*E1FQRK!G!5N'*JH&(1:/=+/>FNLR1*XTG!/I>'PL MVGG,19,$FJ[0K#4'-Y-),SO)$_J#]B(>27^"KCZP(U+# MU0G-*QN7A->K-S?(7.]FSA'VL&2\ 7.5D-,&2K?H45$'VJE,LZ$K'YAQ GO, MI%TYS?GD*;Y/CR=M%PL,K;!,,K: M/8?G^:PHYRQZ@^V@DJNUUS-+X[+4.[[D9@JF6SN.KW2H2;!&M_$#3I9\6J@[ MX(2$Q,#LU^-7"UQ':4(:!.TVA@$JQ$TL XJJFU@:"!A!J7EIKV!9$!@46727 M4-B4(0.#7,$@$57>OM"A $E$0\UTY\)6E**9VQ/=V&61N[=BHZV]S?B-SU(W M^>=N&EQ1F_%U;L5(:KO*E@R&QQ)"PNWKFO<>)% @OWUE1TGX/KB.#*0?H'TRF-HU9D:<)K09Y<$[I4YC6+%-A, $59=T3(ML5@2VE[/12V MS=?1.S"VC83!*'^;N9'.APMI[Z!>ZFP_KY@^K5;=$]#Z$>#B)#SKA9VD59P5 MU;+$=_BI/LKT&R.V_YA74_D,+VEK]5#QC&^C2NHS9JJ=K#K^>UJ1.@-D*:HY M $#CW9+\QPXA @P&7@_Z6XGWCNMKT6#D:*6H.;M!YX);"W!>_#:]S]-9&D=Y M+>?/YIM=C;UVNT=EJ-E2L656Z=#E(H]H5F''XIZ'EG M6IPE=>XG-*XH#7I1IP4RVD]F1;+6LRYU1V.2,#O:L[8C/47=%RM@VMU8\IF MR49]R?X)D&;/HK1DUX.LN[NV_J'9Q*P(XW%1U16[:V4:5?1XY,IE3]%S$_7:1F_E!?2:\F>E",8_;R4;4D6@ M!KO, C4F:%*6-/PO^QV:%W=^"4?B2[!V3I^;*L@*8GX%&]40=9*OKXH8\S&L M(TVOYDBL)$!F,L53\L*=I[;VP&[F4]"NF1 5:[,!(TE'HD/--6:(V2'1$)Q+ MUN70O6L]*@4(RG3L7H\P!Z]7][ZU7KHP]$J7[O'O2^+$3Q\=^LYZN.\-%B;2 MP^T4*BP8C5D(RCO)6CCB>' N<)@AEVT\&GQ(45DWZ2C!8&5EWZ$XT!4,,?7V MH;,]DBN;GLPF7D.G.)#O18HPX,$(RX&D% RW3/,X762X8D?UQ01@J.Q310, M5G4Z)XVU+L;4$.1326J"HG;Z"#!J4=(:ZN,3CY/_F"6P/L;NXYP.VH3 V"W3K90EO5'LE;M4X!Z-*-&TP&U4M,[XZ^ MSU/WP:R#G=\Y8,=L]&=^+49@/*(K4WF6E]FQZ[H;0QBR.Y\OHK2DU>"J/$FK M15%%V=7LHLCO+])'G/#['=V4N%E27N.4/2.SO4AF&Z0#1L+/("]%'NJ2HIU. MFL0N2P/Q1& HG*YLE_@!YQ6AQN.W\=RY3A:ZFOL=]HS+5'\,Y&8+1K$C"4OA M1&CO%?42(5JM@,BS"SWHZ&2U\" !'UV4WFG+7'#[E7& /<+>I\A&9TM4G;,Q&!F.92P?D><@&)JDU]^D M^3T-AL^VD+EY-ZN53_TY9D%4G<4$C-;<>*KN*J -)PWVCI@=#*TQ*KWM[:0. MC=_6.CX9K[L/-LQD;U/"R#2@S?ALR/\5[5"]FLV.HHQ&<[U]P+CF\_BG3PNV ME6S,L&63A+S&8=PXH[U(BZ-3 >."-Z8N#6]FL]TF)<22$D\D )'U<*_1&"4[ MVH;<">:L5R=#<%YW!.E7LFFLB]'"^]>D%;E(HVF:L2O#F@@LR55^@^-E6=+[ MR/+DLLC+]D_24<(,0HPJFV;QZM9&VY$B!92':V$OZRM MRD9)>6UDGI'97INS03I@JL\SR)LJR"1C*A6V#:9D3,$_^"4E#16JB[;>L$>P M>C*H0.3[Y1P#N2OH.%JD=92E?S3G]ACY&URG/)08^TR[L*8HH+=*'A"5Z0EBIE]495'N+WGF^0=.C7*MG)H6#6((2? MZ!E9XZS7"[[M2USSM0]']*W5$VIFDG2&=Q/%ROF1']$[P+(U3S?E:FY4O^;L7QPC.BKU]+10E' NC M%=Q:;_NE>_.O=!3WHH,W,"WSMG.DC_:Z@];C+-J]%)-!GUD:0,YL;N.=7!!W M;=>R[@'?5$T;YLI4VVQ3(:2/9ZB0[''H,WT@8D\$ M4C=YKA1QIVT7$]GMO-Y/Y)J-WC5%-B-HHPY7PE*?"]"62NW.>T6V-*]A7!(@ MCE(8,N=TG$)A#TV<&W '?JRBW17EKDRC18C];XZZ,\"AR=6%"RH\&%TZD-3>_-&3F>,@YB47>8KYO,A9:&'6!B@7= 88>(L(6H;R&7T* M1!5%HD<*A57'A8L[>NNA+"+=#)=D>#S^TA][2H$O8W'-JN5F%ELRX/S'>.Z* MF!/#1?-7)VB^$?@\KS%YSW5U7E5+DN\\H;\8^FU;?0+0"N#Z:C:L&+;D7V.% M<8+S.IVE47>VKMW>U5][:/9V7>)Z?*=G.T\+ M7!.V^:JGVT:^VKEI>YHO56,USO^EZ:\ZS M-KYAV4%W4(Z!+'MN\\5T*[H>"D%XUFNML]+K>JE*VCWH6ZZ5PTR^DNT&EH7O M,!L)3+L&H&EHP OV?H!M"IY#/-2L]D&OU<_V7]1+.5D. 3]]MYW\J2?Y(D [ M#U^@PR=\X:^7V7OH:ZV!^A?XPN,2X0MH[9:7W$HS"1R(LC7R55=7(12>_K174$%=7]D6:J;M4=]$8^F82=7IU:@Y9-*D!*,FGN!I?9Y7=;FD@R73 MKE0ETNN-S7JJ_FVF'* N@7>-RCJ@]6B=0P=H6VL_=A65'J!8= M3E,29;VN.BA0;0WYR?$+>DH">'JMGY^S*,:3.9U9=XI-=E1?=N3: Y@7"J<\F87HDV ]_*RC>^ MFN0[)A'?&AZ?P:&0W5, I>;1M$=)^I4HF'=\-M9N9PY*M8-,C=)K8_MZE-HG M/-+M;N5A\"<:5-%6<'!)>3*<,1X M!Q5?H;BVMJ=[':WH5%&S)*"I13JPWSND3(3[-TBID,'UY$1/L6VL)*Z&Z(D; MP1#/-4F+'??@!UF+.LWO;]+[!^U&!).!WV M-N+]T"PZ-!@Q62D.!<4AJ&28 M0$>Y;R,:*8$Q[IU!X+LH:00O=J(HBG6!8DA-B38"VG6M^8[H5=6%9>MY&P]RONMO(BI$OOGI4J MG%JVK:PH8Q!8JI2E1EU 6U?>^&7=X7)>7\;IR'- MJ+3"#%\VR*YZJ#(B(3CJ?@9[TQ"DL4',"(GIL8">_:]!#38T[\$VE+";^52W M:R;Z5_28;9QA78H61BDD/A3/I[$I4%8*3FZ 9L=E!9>,#%M0,2GNSX(,D M(KM/>47O4J'WBTUU*],&O-\6QD*[W[1HP,%=@"M#N3%I\;3>=Q;L7 H,7;EH M*:!^K)J!J1,7;;BKX07=?[O;MK]# MZJ!5<.WMT\[C,W5WR&;='H+):[JCZ2KL3K! MBZ)*:\6.( L45ME9>4JQ;+@!FE,+E'"3[E#W"L7-,>^(>>5I1(QCC*H'C&N4 MD(;_+:C*R-0WNBZ*5K"*$*X%)0\'0ND?Z@)4CY7)=%C'%2G9&/%$Y;*B0+'E9)N9&5(O\\8+97":7Y M+"N^(OJV$%:U3T%*3)C5<)VDZ9$-W.%/O=UV+\ M%+O.*,04NSD#*F6I+< JRTC7J*SZ:P%JJOVHB,J$/U]73#($5KEH^4DWY5$@ MFG-DT+?>ZF:2)YTZ-&]?#X55"E:>TFZI5O[T'O9U'7EA-\OWP^0TJD3ZB.D] MR =[^S_J/:P9[\VYNM#N)&,"PQ*- ].A;"@ ,3O4&2)J&;9;E0NMPR1OM'TU MH_NJHGRE:P!=K&"5V!C*4D.8HTAL"Z.\;0/Y[38LA:#%N+W#T* *S8'IL*PH M"'V_B,H?NJ/0,Y0,3DK3T]$HJE&=SEF!EGA1E&SF9\%V&2*<)X%F? BC._+? M!?$.Q$UHZI\:!JOLC!R'I<; B*(1A>]0%QFT0JD<_,'>B':K!<,J% >FJW6K7A'E<5,/Q_![ \ZZ:'N^LOYBMYB4U.@RU@QIL?[O@7JOE?:+/ M)W@6+;,:75#K4-H50O<:!"RC +UN [GAJQ>@H?5LB0DOAC0'^:I=WG&H@_FT MC7@HLH2,C?F5PZHW+*.^_ CF11O(2;ON!>B?$ >C25V7Z719TWWUJ"[H%A80 M4I_DB5OIV&Q@5@HS54--85,X'!ZHD(Z+JJ:'0!YQOE2><^D! +U^-2]Y)W!5 M\W,I#!?H);.#8==E,4N5S:SP-: 7K&(EW39%,8B# KW;JP6+*9/?GS[1@WCJ M9E4" 7K/>F[R,=D&B5IHZ'=.!F0%&6!KSH J8!#?NX*=_LUS,/J>PG\(]/K; MN&J-"E2O?@ !]-IUS+0!JAM@L'?=BH/N$SHN(/_$=L]0"TQ30NAU>I[&#:"J()H.Z=,*U%B6.*GR"^<_SO+T- M>WUOML;-6^T %>@8Q*'],$)T>K3Q4-3*EP/ZI2=+<&5)8;D%9= MT,<<:9L(C=?Q/4V'%.P/2L\+JWQYEVO3\E58PR]?$^F1Y=LE!;9\S](\RN-- MRU=A#;]\3:1'EF^75/CRI2S)\(S^H(.FQRBCPR0>7FO8*"EGI$?8 RKCC6A+ M\]FTA.FB ?M%2&<'\920HF4&LQY'CX&QA$)M'R ^AO0'ZA7=AD.G6BC3!1UW71=9&J^,)>MJ M"ZA@1U.6MY?Q!';8QJ6Z6_9CB9 /63+H<_,S?/FRJ9*>DND2YS"\9V6NP2/3 M %3>&U-73CD-ZS,M?$6\X I"Q;Y=3BO\^Y+0.7UDS1-3I$.M=C*$5,2C^$KE MVEDC;@ZP#FN=UEF4EBRNR;I-&>6G%?: "G8CVA9_O3-TV#2M)C;,.K50FPN* M(OF:9IECL1K@@$K1A:6T&:&Q@54\1\LJS7%5'1?S*1F#U?QROO55."P@)0^: MHKR(<(P]H +.DA("$X)W^"XN,_3/\@@/J$[UF<"GO9)WZCRC1DU'-/*?S1N W?:^OZE>_W$F^S MCV1[U.L7J7,.MZK.';2>%M,*E3Q=(4SQHPOR&_FX_8C\0]Z&Y\_[?GI3]X(BST:/##FY.W MQV\&))A1UPL6/[SY<7(TG%SGQ_]]>GERPO]U_/7# MR>D'_K_3XW\#OR5RHCC?LM!6=LF:C,S4CJ?&1D_L.;*9<_$FW@^/W9L?CB/T%D MH_6*]Y+06ZY\#LN[G72]H$%(?<_EK=$]=WR!].21D"C4*:H5W(N68X=QL!Y) MY,T^C!5XXX>.U3[^T;H"U"KK4>L063N#] MGC1P/B)^\D(^W6O;F%JJ2_TF\7+IL/5H/O$6@3?GY/&1>S:C,1^Z@\68XS7S MB!9:LUJZU/\CY5_ F9T1)I#Z[ 3.(B5VS(='G=XPZ2[UO78\EBQV/A,GC%GZ M93HUE4*=MH8B?;Q;AQYDQE=+=:G?)9E&VO5'H4RGV!C/%/N9"=*:S_D2T!T[ M:U![4HATJ=D]\<58RV>&:/W G"!T9J"5@DZNV_%O&I+?8@[!U1,$.EGY_8_) MW8[-?8[1CQ@BF^+^(SK MN=G>_"/7*WB@&15"E(-?IH3_+5X2=R<,^M2DZW4HT-"&HOVN2J$$Z 1[7J," MU=1+[F/%"E06**[2>,5(R(U,FOHM_Z D0IXC$KC$S2L2.G=RELL_%C4=I_^< M#(X&N53Q1R=P!VD5@V(=F?ZY!;S?EI1.^C%E9>R$SB%7.CG0#LGL[8(^O7.) M]T[@*7Y(@#TZ/LF.L__$/_KE@CX1-IR&$>.XYO5QFXF??,LOO$RER+N]Z9:# M],#K;5:M7**J69'W(9L-*.,=DS.2U^6P68GM^FU 5N+=*CF(.YH]>OZFHF0ZZ%*S2Y]IU%,ZB5(D!43S!@;;0&%]=+$LZ8MRJ. M!!)X2R6!*)^BHMQ@&PK8>6^Z)PM/:)TL<_+39_5((1$!PG^&.78HK47E81@$ ML>/?DQ5E&OC+)8&H?XV)>I-MJ&#_(^9+(<+\-03O6F$@Y-]@0BZQ$!7U9.F9 M[*<@L-=+ W'_"^KB1&(C*O"31^+[%W2Y<@)0BV\J#P3_6TSPY79: W]R.B\\ ME. ,%$2 )'QG"PDU:U%Y&!/F47'%S@ ,U H#L7^/B;W$0@M0OPI<*.:;HN!= M$S[D%?-0 ;_VPIGCIWI=\\]"->@-Q:' H^Q7M69: /Z_B,/ T!<*0X%'V<)J M3$2!_2)FK*220N7DX):T:\7@J*-,J&5684 M(L+YB440"<]T%8B$G$3S"A;T<)Q](7P%6+K"^HJAWJ-()04E+VJ@>F(U Q=EX,69O^Y]0)R MHB*DL3CX/@J/!H695H%_:@;^*1Q\E#VLUDRKP#\S _\,#C[*/E9K)C[X%_S' M$7N@7R3WW]+"4.!1]K$:$_%A3^:A$1LS^N2E@;$Z[&L24 (0M[=J8_%9R!8" MD):?EX2BCKC5;38.'^TQ#2/'_[>WTJTYF\M#D4?<]*H,Q3FT3-N ./R0.3A5 MBD!11MGG-IJ# ZQ@FQ%'WI3+):"PHFQ>FXQ!0?66BGN61QHH3WKKI:#HHNQ" M94;A#,C"?SJ4#@:%/X-][%"&VZH9*&#^S+R(ZW%!E\LXR$Y\)/=PDJ)0D%&V MCDKS4 "?)'%M(L+M,U]1,F^;9J&,=E,Y*-0H&T6Y82@XCQD1K!.^6$\\S43( M!1O-Y[(1654>BCO*/E%OJ WXWX1A3)@I"PU24"Y0MHQ0HW%&'A%?R9=))Z?3 M!Q$I)!EW:J6@B*-L%V5&H2!\1Q^8(S+*3=;+*?7E 2^-!:$XHVP.%::A0%W2 MIAGD2A$HO"B[PD9S4$>)J^=9DB9*[D?17!(*,\HN464<\IB\ (W)"\,Q&66W M*#,*%>'4PYWWL='4]Q:EN-EFL!L%P/%#F+@K3,6)5$P"F@K!QM?\AV;P)46A ML..$A*K,PP$\=KU(Y%,0BEWG&3BVV?(DV&NEH#3@Q(P"C4:\1/B9^/[? _HE MF! GI %QTPV"ZAY!*@+E O'N4F,N(A$_43_F6+'$>95)^H.D*!1XQ#M+B7F8 MGJ*I4_9F9DHS1JMPETE X4>\O%0;B^I!%Q&AN4A/Y$1.IJ>*!9D$E 7$BTRU MLCN(H>=N+:ZD\=E#*00G"#%H%&(ZZ4@JWP6S$/5_?DSEAPF'B@3Q'Y_SK M?E4OG #B4)90LR^!86@@Z_MW-;MN^0<]IZ#5O[15RC][.C@:;$[?^<\7H[O) MZ/;F5-D3B1V'^ M2;5%9A__4G@6:7-G,*;I]D*1I#83ATFW[F.[FYT)+D@&&F#QC8AG)T5 M\/7AC'A/X@V5.Q+)E\NYS4HIM+RY+1B!V&\'4Y=\!<^'U[!DG9PB27&T[+HM MN%%:; 06OPOE8E M@Y=,MRT-4A:MWOSF6Y.QLQ;[$O"FK%H>+P&>28*8D52F$EQ*Y&Y(!B-@QEK8Y#NG@ *2'/+[=$'.F MT/W-,6I#8;RDOW"HJZ?!4IOM(*7@^J9AI%X2+Q5P6SIDUMK!Q=!UDT-/QQ\[ MGGL37#@K+VK,=98?R\@$\'($MV5&8[L=!-V+U^P#XHK3&>'#.YS-XF6<;$,N MR5QDQ!"FL4.D9MF2PH>_(@L572[I$N^/):S(REN&2NJ%ERHZ#!AA8<=>K+17Y,#R MF5+ RG_V28)OX Z7(D;V]^1SJ6.ET@&GHV^P);:K-@77'74ZQ=2.EE)NT7P= M/F()(FYRB#*?-^WV[Y=.35Y;## MS5J2)@/ 7K*23)2&1.4RV//H3B25#;>7('6Z!H6!;?(U]'AUL -5/25NZ/2> MS7S^ @ECQ["!>3. PCKNX-.64@@[%*T-5W9/6#5%=;.55 []JP]-S;.4X8Y MA62FM9FA>O.F:\\0;'K"OT?99H ?S4=\AUAY ZYTA_*UZ@YE\L#_\_GJ[F$R M&%T/1N.K^^'##2\P^.K'P$F3SV/>I(A\0DNRT5Y_>2(50/5*>")!K/);W)9 M/L?0X%US+B@;9LN(%D:C>::;OL5(BF,?-9@QH;39#EJ2:)Q4SVS$"A:9PG)R ME$+8!PMJT!MBD=36VT%3\512SDNY%/;A@0D13?;9@7S)"N!XA7\:8()]HX6' M[N7TD=$P'#,Z5SD7E@IA'P2832T-]ATZ99L1^.IY18*0 '()*D2PSPK,Z-3: MWE.PN-B]Q+[XXFM"PD)L8),;8'9A*A7 /@+0@TAAANP1HMH Y-E9)5-+(J)CX1A$O@@ MZ46;VXYJ2?3$/:;TR(RU@XJ:-0:SM04Y>(S[BLS<%[/Z2AI"-AE"$!.:&5"*!G #);2&L,MV/,K"@)9L6"=#\Z?)5L MM.]=[]/>%9"%6*;;T+_R$>.:(Y1&_S-K<\YF5-&TG(/SC,)/WL!9?EC MD1P3OM(JUY(ZK7XFT2/E?WGB160O*)=ZQIZ40,]@9#H.[)V@PY\S,BBRWGK. M=P3*XS.I 'J&I#9M16JX'7/&'8D@*[-*,?0$2&9,-!IYZ/TJ#_+.O;3.G="; M\<'ETO/C2.5KHQ5$3Y!DQBX0"#OZV\_$6SQRK89/?,)8D/2UP]$\4;S@CP(F MLVU]Z/F1S#C>#3:[O7I&\XM')UB0\"90A(:7O'R^ 7GY"">?BT_#NX]7D\'- M'?]\=/'W3Z/;RZO[R?\X*QK^=7#UCQ]O'OYEB?M/ 9!V2:5 XC8$C1YZ*'6+ MM!>OL=26Q.O>OL926\O-:RSUGEGI+);ZFWT%4T\($UEDVD535X2QO1Z-:# Q MS*8%?\'K7$K:QF.J5A3;Z[%-3Y%:; D6V( B%A!VG5S'8Z MMF3EL1THV]"DMMT.?O:4R0\_UK^'Y&TK/GE1<1S (OQ318.PL/:Q8/C1_Y ML$-F4;32- #Q,F;6$?-"$S7E+]^L6.U6)','32 MK<'P6=T2TE;J"?,=FH?,[X/UR?=DTO8D@RXC5N,!@:[_=9"WG^=\/': MIU\DR:B^A2>CNAA./@VN;T<_VY*,JCA*Y58:=;T&*=PEJ5!HS.@3WR"YY^L? M0[&$WL2J#?DR^BE]H49K9)NZ[.FE4C;KJ]R6B-FQ%.[7L[\OHG9 O4^?_R?" MIC0D^(OBH?M_<18@)-Y1G]%@YOFD9.P#[:RG]_-MV+>$G;6Q/LFP8Q YQ 1A MO;)R*/G%DN0;#0;EL]]F0I2S:E %]NW@'BDW!O;PYQP.(B-.2"Y)^M\";)G+ M&"A5*[@.[ O'SN8'<^#L&#SJ>@]G,QKSWI7>J:C#5V#2V#>)+;C1D2L'Z45D M)JA8R^<^\9!B,AX.PY!H4@H I+%O''MH$G*07F*3R#O V%F+UB^2?LUF+.;* M;A_ ;3-NJ.O#OM#L<22! &G'E &?,[LX5\*_+.WRG,(0N$-/7""Q.$U]TLU1 MI+(N>VYX=SZ,!&!F]?#0H'\77%MP][L#86V9?^'C0_9^=R?C@[(N](2#W8T/ M ,SL&!^XXC-"W"0?EG#OXEH3X9NYB2244PP014\VN ,]M:2M,)PLII6EU]XZ M]RR(+'K>PGZ);42JI_SA105$I"&?73[3@*RS'6P#3T),*X6>WV]WAD!VVMKK MBAGH+\E4,56JI=!S[_72TV3HV,$CW.0N%D 69/7KC&-SY Y]T2S,'0:N^(^8 M+I[XQ"'.CQ(GT.KYDKRUF-6"GB>PQ4*Y#4XOH6VH.;<@'V!++G?FR*JX;3U3 M!H[MIS8=8.6Z=\*6'>$)\6KE)R@X?H["33"G;)D2H?<5A58 Y;O_0 8XWX;H MV+'@RE-TBW0X? FANJJJ%(12U-^9D2'>S0GU*X;;PLHFESJ F'I9*#?]Y:78 MD1N9^3V=!!35O:.!V=@F:C"I $I._XDE &.;J7$V]:)"0/R)8DXJE8*2T_WA M34NDI3D 3A1DX(34C-C"";S?4SL"]Y,7 M.($[R,41'4X+*FW#A5+CQ@7T1O-L%^[XVT@BP).+ETV'HTGWB+P)M[,R>(,O\BD1:%VSLK MGH.5!I[WU8$GJVQ YX-"=8-M?8--A8@Q,C7K )$N"AG,65O%&6 H@,HC=W ] M8]6IW0@7:_KB1RJ< FDP(TR,+Y^=P%FD(\G8=X+&/GAR7.V#226#K)9D]B_4 MDX6T)]5UN"=0*Z[9#T"%40]SIB+W0L1']TL:3Z/AE,9146](7S.H ZN_F= A M.="S)!?>9.*(KE5]9*_6YDVJ?$[*#1'A0DL9KL1MKMGH"ICFU M%&(';%(,T.JTMI8L+2"WTGB- M\#P.O8"$X05=3OEB/WG/4=^GU%*(?:I!,:-])%0>N9=!6*OT,C-DK.EN)1>5 M4N?ZO5-ZFK(5W- +T&IT<]G5#336C_F10!7IV(0A_VO2-&H0Z3B2 MTV]32\^=4'A=KA5;L&^J'3>5'"2B@XTLXORP42YQP!=//&=IAQ.?T@L:1F&2 MS6U:-!8P%>Y8+^:4"56]Q#]D:MVU8NPIN).V4IVJNT';FBF]Z(Q=2.TL&1_^ M4AT?,O%!(C\H58#Y;E6S3?IA0"^)^AQ7LW)&\[M1)<@=&,IC[>DN8YRLZ8[B MI)?\%O-*KY[DT_2W]1O"7&R0R>&>ZA=-@/ADRB20+R>*2@'O(B0BV&ME#2<- M]PU*VRWJ+Y![=N5]^TG-T0=^WS[X*O\),VON"[IZ+SF#))JM 1U/+75HU^P0 M#.QP;_PQ%(&R8>0M^82KB(>KEL/.=VM,2;.A=I @":X"]QV8.';Z6/->9 *+ M)4R*R_P@RAY2\L)?+QAQO4C\I!S[Y$+H66%;C'TZ".S@BF\L7)$B+$TR5\M! MF+8S.6M $;Q6%'T[$51>CQ4J?P\^[>$[[EB8G(9\R7_D;+4( H=@)6XP8 AL..SGRS7#D>2R*+&-_3K6CH M^*/Y+0T6M^)5PC0;*)C0=K5A9U0UYG@7T.R@79S$,_)(@I KG,;NI?H:;"&A M-6!G/FVQIC(#QPY*-Q&8\-XJE<#.6VK>(S7&VT'11TK=+Y[O\W7!#4A"M@8SS6@SB;D]R.UJ*1 M)5%9@Z_26C O0E]J>%:Z9N334^$EB@Q[=Q3SPF&J/'%"/ :2T66A)#9L,(\,*"R2:S1^+&(AUUKF(! M[_!\7600,(VWJNWP LUV0\)7G@_[]-;P,_D^64L ;\TQ%4J.HL,TDZ;RWKI9 #OB0#H7UF^G519;2LLHCD1&)I=O^@VX*4EA M]Z'V##48;\VV"180HMQ&U7/F&,2#6+"Q>DGA(.E3OM[O661M\R[U/FWE %B)J'-\[ MXUZT_("XN>L1'XGB99R$M%\2OO1H?!8R$X;(HHVL.Q,.1Z;C5F#15?WV;N.. M!D?S_.A4?5\IBI8O*97#=BU]E_3*/]=&+(W%EVR.<@>I0LD07U I%W<'-$@$ M-C>I@T2M/UNQ@'YU(VB^U-Z#]X MAWF8O@/6W&=T85'M<*&?QG-KVRU*YYVN MA]9V:]W=S<:J\W5AHKEFB8_>;*V^QP$)_\%:APH*.ZZ&FE8Y&T5UET,@8\+.J/R[#8<*6730I3&RO /AXR:+4 -A48V7&"5VB\FQ\_>81Q MO1[7M^2)^."A62EO65?M?W16HE'(J6(#]\4&6]>[S5"MJ,:RE@!J]Y">+K?8 MKA'\)EC%49B8> (>M9N$;!RIMPOK[H.ST4 M^L[:T'=F2%]OD79]T7=F(WWI(L*H02B%L.?RMOP#D'@1GA;-H7EW#A/I M$)^(\LZN]G*'-$AO4Y\=EVU_X(@]35B/<4UV[)E[#MBSZH:L0=W:&@<4TG!K MV_U5VW:L#W.XM>[6Z<5%#/7&G4T71Z\Q1:\Q1:\Q16;!*V.'C5@2^.$F"^D\ MK9F\JX"$+:1.=]1@ (IU+.XG,JRW;>!N;+T&B>WS_+8+KF#A8KB$)1T?1%)6 M$CLS_V[$E,Q]P6BS_16*_%;2:]!HM@@HKDK=:Y;S:( 'JSV#;^V8U-K([ G@PO._^VEH3=]KRWEQ7XVGOZ8J9_'P?3P[Q2EF MHAVD);=/[NZKS4N_'?O-VP-N^1I&7]M_$:V-5_A^&GSAZ[ ?]3W<%E[C[/"; M=.ZL+F^%VQ+8+P7OM^%4D3E\KKO$+RVRG[$K_R[LIXP/=^ JL_6ZK:\M6@I_ MV.L"M/2]V.\^'V[[EK/XAQVU"Z\Y-[+3>3/7?R'ZD]@'T<"AQ'4ZBN-XP5V2 M::1T4_NVZJ8F)*QP'$M4-XB8EY5'S7,^C6X"KD@,>+6KL; =;@IJ*FIYSQOL ML,2?JZQ;[7Q=1TI!P!YB) U,R4K!D'Y\M$(6%5CAOU49X1_]\B!&HM'\)G"] M)\^-'5G.,%Y64O1@6)";T(NS53OX?_:BQWOBIRZ=C][J@5[Q&3229_)JLDI7 M"3)EC/@O,\*$T_IRY01KI2\64!;--:,- MRG4G+2.$[+C5+ \9:F_4IK(',_ I;+ CFV%9LSMGJ?4NE4O8R(K"GU1N2#\C MV8]!*+(_B6>* K[YCSS>7L9<>R\,*5O?T8@H!S.X.+:KF:Y-%04Y1 ]A[5[ F4?:9NN(WTY.Z']WR"3,.:QX3-!,0+\'Y478== M'UI>/(S/DE&7@O?"<,A\J36J L M]JF1LCT5E\E&6-BQ7I[$T]!S/8>M)XZX7TO4U8QF%4T$M M<3,PFB=QP7SAPK'4#6D064NXTK6_*FT RZQX$&O,O"?>#,<^WRR+MJA[C4=6 M'ONL!MX,:X]OJ "P8_0KC]*P]*@J&>0K*ODFH<:-SFY[^0$E1]4*8J\I=J+* MVL2H965_HA'7\-Y;/*KBDU0RV'=++5EJ,MP.@JQ)Z=W;C1&8LL-/Y#V,HT?* M1 P#B+.Z$/K:H@57,M,MY:CO9.N]W0ZUY\;&A01BBO7>KHC:,V3M^J&PV2BE MQ$IS6(AG(@N[#]#V%U(-=C0]F,A6\!Q^W&5Q"QJ+323_I3#2W!@W"D MV!'N M;=H$&)P7U202=RW]XE4N@1WLW8;J1J,M&<.%?FGCNXS%"[Y<38^F"^OTXVO* M)H0]<0N4=V9&U:!'-,-9;(./U=06QYM=N)76 R47_[2F'4)VL&NYC^D)_BG/ MJW]II_ZE)_B'0!WXEN*XTJ5WTN=.2-RQLQ::ADI?NO=57[K,<2ZI89!7884? MW5;--#23\.5KNLOQQ0G=!0VC,.EHTZ+U@,0/.]9KQ6M"B8():443AHPO\A=) MBP_/U]LRF1'#+PYSP<\,[?P5=MPL=].,I"\4[8R2+8Z%.CMD9M2&UH8VU4'= M=C2FSCM@M5UU@)0E/I)CWPF$IX#:B:ACXR&;4_$E#5B#Q3]M9L=0;9F MJYYM.,8.B]:%RQCE?OWLN+I?SVH9)-4,BO58L6F7&:G?ENLEK=AXR]0\7Y?^ M MUD&U5GQV(+2K%TRVQDLR7;8XG.@,VO7M(.6G=JXA6N]3:_II&T@[#71).6 M[&0/,-'D-HEBDD Q5*>6E)4^]&22:A1Z2D)2^-91("R(0E,69')HSL"=\Z%& MIB=FSBG?TZ3?I*:BJ2":LV\WV,MM[PGLG-EAX&YX5X*N$D#SX^T&?#T6=AR: MO(Q4MEVNEE^3W>[Q-O@UV:U5N3=??K);2_)N]D4G]&#D9>3?M-RIV2Z.7SV< M^_)P[LT%MENF>W9WEF>2#S)$^9VARKA!N)UELD\ Y[ MZD["TN3^4=E?Q+]$N 3_Y/\!4$L! A0#% @ RU5D49_W3H3*2 3E " M !$ ( ! &)L86(M,C R,# Y,S N>&UL4$L! A0#% M @ RU5D48SQD$]L"0 R$T !$ ( !^4@ &)L86(M,C R M,# Y,S N>'-D4$L! A0#% @ RU5D469G:=]A# -Y, !4 M ( !E%( &)L86(M,C R,# Y,S!?8V%L+GAM;%!+ 0(4 Q0 ( ,M5 M9%%).$,H\Q, "!# 0 5 " 2A? !B;&%B+3(P,C P.3,P M7V1E9BYX;6Q02P$"% ,4 " #+5611':Y>MDLS 1X ( %0 M @ %.

&UL4$L! A0#% @ RU5D M46ASPCK.) X5X" !4 ( !S*8 &)L86(M,C R,# Y,S!? =<')E+GAM;%!+!08 !@ & (H! #-RP ! end